Suzanne Cannegieter
Professor Clinical Epidemiology, in particular thrombosis and hemostasis
- Name
- Prof.dr. S.C. Cannegieter
- Telephone
- +31 71 526 1508
- s.c.cannegieter@lumc.nl
- ORCID iD
- 0000-0003-4707-2303
Suzanne C. Cannegieter is professor of Clinical Epidemiology, in particular Thrombosis and Haemostasis. She is staff member at both the department of Clinical Epidemiology and the section Thrombosis and Haemostasis of the department of Internal Medicine.
More information about Suzanne Cannegieter
Suzanne C. Cannegieter is professor of Clinical Epidemiology, in particular Thrombosis and Haemostasis. She is staff member at both the department of Clinical Epidemiology and the section Thrombosis and Haemostasis of the department of Internal Medicine.
Clinical Epidemiology
Research into understanding of disease starts with comparing large groups of individuals and observing average differences. Epidemiological methods allow to some extent establishing that such differences are causal. Only when a large amount of knowledge is present, determined at group level, is it possible to quantify an individual’s risk of disease. Currently this situation is gradually transpiring. We think less in terms of ‘what is the cause of a disease’ but more in ‘what are the causes of the disease for this patient at this moment in time’. This knowledge leads to determination of individual risk profiles, which provides new options for prevention or treatment of disease. This principle can be applied to every disease.
Suzanne Cannegieter applies this principle mostly to the disease venous thrombosis. Hence, her group studies causes of thrombosis, as well as individual risk profiles. With this knowledge, thrombosis can be optimally prevented and treated.
This research contributes to NWA questions about health care research, prevention and treatment.
Academic career
Suzanne Cannegieter studied medicine at the Universities of Groningen and Leiden. She obtained a PhD degree in 1996 at the Leiden University with as title: “Optimal oral anticoagulant therapy in patients with mechanical heart valves’”. In 1999 she obtained an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine. During this period she also was a visiting lecturer at the London School of Hygiene and Tropical Medicine and the Department of Haematology of the Charing Cross and Westminster Hospital. In 2003 she was appointed as clinical epidemiologist at the LUMC at the Department of Clinical Epidemiology and since 2016 also at the Department of Internal Medicine, section of Thrombosis and Haemostasis. In 2016 she was appointed professor of Clinical Epidemiology in particular Thrombosis and Haemostasis. The title of her inaugural lecture is "Models of Numbers and Blood”. Since 2017 she is visiting professor at the Universidade de Minas Gerais in Belo Horizonte, Brasil.
Prof. Cannegieter is a member of the Education Committee of the Council of the International Society on Thrombosis and Haemostasis (ISTH) and co-chair of the ISTH Scientific Subcommittee on Predictive and Diagnostic Variables. She was board member of the Netherlands Society for Thrombosis and Haemostasis (NVTH) and was a member of the Local Organizing Committee (Education) for the 24th Congress of ISTH, held in Amsterdam 2013. She is a member of the Scientific Advisory Board of the Dutch Thrombosis Foundation and member of the Science Committee Medisch Centrum Haaglanden. She is Associate Editor for ‘Research and Practice in Thrombosis and Haemostasis’ and member of the Editorial Board for the Journal of Thrombosis and Haemostasis and PLoS Medicine. In2010 she received the LUMC Marie Parijs award for her studies into venous thrombosis.
Professor Clinical Epidemiology, in particular thrombosis and hemostasis
- Faculteit Geneeskunde
- Divisie 2
- Reumatologie
- Klinische Epidemiologie
- Nemeth, B.; Smeets, M.; Pedersen, A.B.; Kristiansen, E.B.; Nelissen, R.; Whyte, M.; Roberts, L.; Lusignan, S. de; Cannegieter, S.; Cessie, S. le & Arya, R. (2024), Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty, Journal of Thrombosis and Haemostasis 22(1): 238-248.
- Visser, C.; Berentschot, J.C.; Jong, C.M.M. de; Antoni, M.L.; Bek, L.M.; Berg-Emons, R.J.G. van den; Borst, B. van den; Cate, H. ten; Cate-Hoek, A.J. ten; Braeken, D.C.W.; Geelhoed, J.J.M.; Heijenbrok-Kal, M.H.; Kuijk, S.M.J. van; Kroft, L.J.M.; Leentjens, J.; Roukens, A.H.E.; Cannegieter, S.C.; Klok, F.A.; Kruip, M.J.H.A.; Hellemons, M.E. & Dutch COVID & Thrombosis Coalition (2024), The impact of pulmonary embolism on health outcomes of COVID-19 at 3 months after hospitalization, Research and Practice in Thrombosis and Haemostasis 8(7).
- Meijgaarden, K.E. van; Veen, S. van; Tsonaka, R.; Ruibal, P.; Roukens, A.H.E.; Arbous, S.M.; Manniën, J.; Cannegieter, S.C.; Ottenhoff, T.H.M.; Joosten, S.A.; BEAT-COVID Grp & COVID-19 LUMC Grp (2024), Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease, Scientific Reports 14(1).
- Touw, C.E.; Nemeth, B.; Adrichem, R.A. van; Schipper, I.B.; Nelissen, R.G.H.H.; Lisman, T. & Cannegieter, S.C. (2023), The influence of lower-leg injury and knee arthroscopy on natural anticoagulants and fibrinolysis, Journal of Thrombosis and Haemostasis 21(2): 227-236.
- Chu, G.R.; Seelig, J.; Cannegieter, S.C.; Gelderblom, H.; Hovens, M.M.C.; Huisman, M.V.; Hulle, T.V.; Trines, S.A.; Vlot, A.J.; Versteeg, H.H.; Hemels, M.E.W. & Klok, F.A. (2023), Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice, Research and Practice in Thrombosis and Haemostasis 7(2).
- Jong, C.M.M. de; Visser, C.; Bemelmans, R.H.H.; Boersma, W.G.; Borst, B. van den; Burggraaf, J.L.I.; Cannegieter, S.C.; Cate-Hoek, A.J. ten; Croles, F.N.; Faber, H.J.; Faber, L.M.; Hellemons, M.E.; Hessels, L.M.; Huisman, M.; Kamphuisen, P.W.; Koster, S.C.E.; Kroft, L.J.M.; Lee, I. van der; Leentjens, J.; Meijer, K.; Ninaber, M.K.; Sondermeijer, B.M.; Stads, S.; Noordegraaf, A.V.; Winckers, K.; Kruip, M.J.H.A.; Klok, F.A. & Dutch COVID Thrombosis Coalition (2023), Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism, European Respiratory Journal 61(4).
- Camilleri, E.; Rein, N. van; Vlijmen, B.J.M. van; Biedermann, J.S.; Kruip, M.J.H.A.; Leebeek, F.W.; Meer, F.J. van der; Cobbaert, C.M.; Cannegieter, S.C. & Lijfering, W.M. (2023), Influence of rosuvastatin on apolipoproteins and coagulation factor levels, Research and Practice in Thrombosis and Haemostasis 7(2).
- Crobach, M.J.T.; Anijs, R.J.S.; Braekkan, S.K.; Severinsen, M.T.; Hammerstrom, J.; Skille, H.; Kristensen, S.R.; Paulsen, B.; Tjonneland, A.; Versteeg, H.H.; Overvad, K.; Hansen, J.B.; Næss, I.A. & Cannegieter, S.C. (2023), Survival after cancer-related venous thrombosis, Blood Advances 7(15): 4072-4079.
- Chu, G.R.; Seelig, J.; Cannegieter, S.C.; Gelderblom, H.; Hovens, M.M.C.; Huisman, M.V.; Hulle, T. van der; Trines, S.A.; Vlot, A.J.; Versteeg, H.H.; Hemels, M. & Klok, F.A. (2023), Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 230: 98-104.
- Touw, C.E.; Nemeth, B.; Adrichem, R.A. van; Vlieg, A.V.; Nelissen, R.G.H.H.; Lisman, T. & Cannegieter, S.C. (2023), Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy, Thrombosis Journal 21(1).
- Crobach, M.J.T.; Anijs, R.J.S.; Braekkan, S.K.; Severinsen, M.T.; Hammerstrom, J.; Skille, H.; Kristensen, S.R.; Paulsen, B.; Tjonneland, A.; Versteeg, H.H.; Overvad, K.; Hansen, J.B.; Næss, I.A. & Cannegieter, S.C. (2023), Survival after cancer-related venous thrombosis, Blood Advances 7(15): 4072-4079.
- Kapteijn, M.Y.; Kaptein, F.H.J.; Stals, M.A.M.; Klaase, E.E.; Eijk, R. van; Ruano, D.; Duinen, S.G. van; Cannegieter, S.C.; Taphoorn, M.J.B.; Dirven, L.; Koekkoek, J.A.F.; Klok, F.A.; Versteeg, H.H.; Buijs, J.T. & Garcia-Ortiz, I. (2023), Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 221: 10-18.
- Kempers, E.K.; Chen, Q.G.; Visser, C.; Gorp, E.C.M. van; Klok, F.A.; Cannegieter, S.C. & Kruip, M.J.H.A. (2023), Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020, Scientific Reports 13(1).
- Yap, E.S.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2023), Coagulation factors II, V, VII, IX, X and XI and mortality, Research and Practice in Thrombosis and Haemostasis 7(6).
- Camilleri, E.; Smit, D.L.; Rein, N. van; Cessie, S. le; Hon, O. de; Heijer, M. den; Lisman, T.; Cannegieter, S.C. & Ronde, W. de (2023), Coagulation profiles during and after anabolic androgenic steroid use, Research and Practice in Thrombosis and Haemostasis 7(7).
- Joosten, S.A.; Smeets, M.J.R.; Arbous, M.S.; Manniën, J.; Laverman, S.; Driessen, M.M.G.; Cannegieter, S.C.; Roukens, A.H.E. & Leiden Univ Med Ctr BEAT-COVID Grp (2023), Daily disease severity in patients with COVID-19 admitted to the hospital, PLoS ONE 18(9).
- Burggraaf, J.L.I.; Rein, N. van; Klok, F.A. & Cannegieter, S.C. (2023), How to predict recurrent venous thromboembolism and bleeding? A review of recent advances and their implications, Polskie Archiwum Medycyny Wewn�trznej 133(5).
- Luijten, D.; Talerico, R.; Barco, S.; Cannegieter, S.C.; Delcroix, M.; Ende-Verhaar, Y.M.; Huisman, M.V.; Konstantinidis, S.; Mairuhu, A.T.A.; Mens, T.E. van; Ninaber, M.; Pruszczyk, P.; Noordegraaf, A.V. & Klok, F.A. (2023), Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis, European Respiratory Journal 62(1).
- Anijs, R.J.S.; Nguyen, Y.N.; Cannegieter, S.C.; Versteeg, H.H. & Buijs, J.T. (2023), MicroRNAs as prognostic biomarkers for (cancer-associated) venous thromboembolism, Journal of Thrombosis and Haemostasis 21(1): 7-17.
- Goedegebuur, J.; Abbel, D.; Accassat, S.; Achterberg, W.P.; Akbari, A.; Arfuch, V.M.; Baddeley, E.; Bax, J.J.; Becker, D.; Bergmeijer, B.; Bertoletti, L.; Blom, J.W.; Calvetti, A.; Cannegieter, S.C.; Castro, L.; Coma-Auli, N.; Chavannes, N.H.; Couffignal, C.; Edwards, A.; Edwards, M.; Enggaard, H.; Font, C.; Gava, A.; Geersing, G.J.; Geijteman, E.C.T.; Greenley, S.; Gregory, C.; Gussekloo, J.; Hoffmannu, I.; Hojen, A.A.; Hout, W.B. van den; Huisman, M.V.; Jacobsen, S.; Jagosh, J.; Johnson, M.J.; Jorgensen, L.; Juffermans, C.C.M.; Kempers, E.K.; Konstantinides, S.; Kroder, A.F.; Kruip, M.J.H.A.; Lafaie, L.; Langendoen, J.W.; Larsen, T.B.; Lifford, K.; Linden, Y.M. van der; Mahé, I.; Maiorana, L.; Maraveyas, A.; Martens, E.S.L.; Mayeur, D.; Mens, T.E. van; Mohr, K.; Mooijaart, S.P.; Murtagh, F.E.M.; Nelson, A.; Nielsen, P.B.; Ording, A.G.; Orskov, M.; Pearson, M.; Poenou, G.; Portielje, J.E.A.; Raczkiewicz, D.; Rasmussen, K.; Trinks-Roerdink, E.; Schippers, I.; Seddon, K.; Sexton, K.; Sivell, S.; Skjoth, F.; Sogaard, M.; Szmit, S.; Trompet, S.; Vassal, P.; Visser, C.; Vliet, L.M. van; Wilson, E.; Klok, F.A. & Noble, S.I.R. (2023), Towards optimal use of antithrombotic therapy of people with cancer at the end of life, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 228: 54-60.
- Kroone, C.; Tieken, C.; Kocatürk, B.; Paauwe, M.; Blok, E.J.; Ünlü, B.; Berg, Y.W. van den; Stanganello, E.; Kapteijn, M.Y.; Swier, N.; Zhang, X.; Duits, D.E.M.; Lin, Y.Z.; Oostenbrink, L.V.E.; Akker, R.F.P. van den; Mosnier, L.O.; Hawinkels, L.J.; Vlijmen, B.J.M.V.; Ruf, W.; Kuppen, P.J.; Cannegieter, S.C.; Buijs, J.T. & Versteeg, H.H. (2023), Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer, Blood Advances 7(11): 2388-2400.
- Anijs, R.J.S.; Chen, Q.; Hulle, T. van der; Versteeg, H.H.; Klok, F.A.; Lijfering, W.M. & Cannegieter, S.C. (2023), Venous and arterial thromboembolism after colorectal cancer in the Netherlands, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 229: 90-98.
- Kaptein, F.H.J.; Stals, M.A.M.; Evenhuis, R.E.; Gelderblom, H.; Huisman, M.V.; Karis, D.S.A.; Noten, R.W.D.; Cannegieter, S.C.; Speetjens, F.M.; Verschoor, A.J.; Versteeg, H.H.; Sande, M.A.J. van de & Klok, F.A. (2023), Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 221: 19-25.
- Smeets, M.J.R.; Touw, C.E.; Rosendaal, F.R.; Nemeth, B. & Cannegieter, S.C. (2023), The risk of venous thromboembolism after minor surgical procedures, Journal of Thrombosis and Haemostasis 21(4): 975-982.
- Chen, Q.G.; Toorop, M.M.A.; Tops, L.F.; Lijfering, W.M. & Cannegieter, S.C. (2023), Time trends in patient characteristics, anticoagulation treatment, and prognosis of incident nonvalvular atrial fibrillation in the Netherlands, Jama Network Open 6(4).
- Chu, G.R.; Seelig, J.; Cannegieter, S.C.; Gelderblom, H.; Hovens, M.M.C.; Huisman, M.V.; Hulle, T. van der; Trines, S.A.; Vlot, A.J.; Versteeg, H.H.; Hemels, M. & Klok, F.A. (2023), Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 230: 98-104.
- Anijs, R.J.S.; Laghmani, E.; Unlu, B.; Kielbasa, S.M.; Mei, H.L.; Cannegieter, S.C.; Klok, F.A.; Kuppen, P.J.K.; Versteeg, H.H. & Buijs, J.T. (2022), Tumor-expressed microRNAs associated with venous thromboembolism in colorectal cancer, Research and Practice in Thrombosis and Haemostasis 6(5).
- Touw, C.E.; Nemeth, B.; Lijfering, W.M.; Adrichem, R.A. van; Wilsgard, L.; Latysheva, N.; Ramberg, C.; Nelissen, R.G.H.H.; Hansen, J.B. & Cannegieter, S.C. (2022), Effect of lower-leg trauma and knee arthroscopy on procoagulant phospholipid-dependent activity, Research and Practice in Thrombosis and Haemostasis 6(4).
- Roukens, A.H.E.; Pothast, C.R.; Konig, M.; Huisman, W.; Dalebout, T.; Tak, T.; Azimi, S.; Kruize, Y.; Hagedoorn, R.S.; Zlei, M.; Staal, F.J.T.; Bie, F.J. de; Dongen, J.J.M. van; Arbous, S.M.; Zhang, J.L.H.; Verheij, M.; Prins, C.; Does, A.M. van der; Hiemstra, P.S.; Vries, J.J.C. de; Janse, J.J.; Roestenberg, M.; Myeni, S.K.; Kikkert, M.; Yazdanbakhsh, M.; Heemskerk, M.H.M.; Smits, H.H.; Jochems, S.P.; Collaboration BEAT-COVID Grp & Collaboration COVID-19 LUMC Grp (2022), Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8(+) T cell responses following COVID-19, Nature Immunology 23.
- Etten, E.S. van; Kaushik, K.; Jolink, W.M.T.; Koemans, E.A.; Ekker, M.S.; Rasing, I.; Voigt, S.; Schreuder, F.H.B.M.; Cannegieter, S.C.; Rinkel, G.J.E.; Lijfering, W.M.; Klijn, C.J.M. & Wermer, M.J.H. (2022), Trigger factors for spontaneous intracerebral hemorrhage, Stroke 53(5): 1692-1699.
- Visser, C.; Biedermann, J.S.; Nierman, M.C.; Meer, F.J.M. van der; Gulpen, A.J.W.; Moors, Y.C.F.; Cannegieter, S.C.; Lijfering, W.M.; Kruip, M.J.H.A. & Dutch COVID Thrombosis Coalition (2022), The immediate effect of COVID-19 vaccination on anticoagulation control in patients using vitamin K antagonists, Thrombosis and Haemostasis 122(03): 377-385.
- Mohammed, Y.; Touw, C.E.; Nemeth, B.; Adrichem, R.A. van; Borchers, C.H.; Rosendaal, F.R.; Vlijmen, B.J. van & Cannegieter, S.C. (2022), Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy, Journal of Thrombosis and Haemostasis 20(3).
- Ramberg, C.; Hindberg, K.; Biedermann, J.S.; Cannegieter, S.C.; Meer, F.J. van der; Snir, O.; Leebeek, F.W.G.; Kruip, M.J.H.A.; Hansen, J.B. & Lijfering, W.M. (2022), Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE, Journal of Thrombosis and Haemostasis 20(4): 877-887.
- Lith, T.J. van; Sluis, W.M.; Wijers, N.T.; Meijer, F.J.A.; Kamphuis-van Ulzen, K.; Bresser, J. de; Dankbaar, J.W.; Heuvel, F.M.A. van den; Antoni, M.L.; Mulders-Manders, C.M.; Mast, Q. de; Veerdonk, F.L. van de; Klok, F.A.; Tuladhar, A.M.; Cannegieter, S.C.; Wermer, M.J.H.; Worp, H.B. van der; Huisman, M.V. & Leeuw, F.E. de (2022), Prevalence, risk factors, and long-term outcomes of cerebral ischemia in hospitalized COVID-19 patients - study rationale and protocol of the CORONIS study, European Stroke Journal 7(2).
- Kaptein, F.H.J.; Stals, M.A.M.; Kapteijn, M.Y.; Cannegieter, S.C.; Dirven, L.; Duinen, S.G. van; Eijk, R. van; Huisman, M.V.; Klaase, E.E.; Taphoorn, M.J.B.; Versteeg, H.H.; Buijs, J.T.; Koekkoek, J.A.F. & Klok, F.A. (2022), Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma, Journal of Thrombosis and Haemostasis 20(7).
- Haalen, F.M. van; Kaya, M.; Pelsma, I.C.M.; Dekkers, O.M.; Biermasz, N.R.; Cannegieter, S.C.; Huisman, M.V.; Vlijmen, B.J.M. van; Feelders, R.A.; Klok, F.A.; Pereira, A.M. & Endo-ERN Cushing Thrombosis study (2022), Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN), Orphanet Journal of Rare Diseases 17.
- Latijnhouwers, D.; Pedersen, A.; Kristiansen, E.; Cannegieter, S.; Schreurs, B.W.; Hout, W.V.; Nelissen, R. & Gademan, M. (2022), No time to waste, Bone & Joint Open 3(12): 977-990.
- Stoevelaar, R.; Juffermans, C.C.M.; Roorda, I.M.M.; Nijs, E.J.M. de; Hoornweg, J.; Cannegieter, S.C. & Linden, Y.M. van der (2022), A simple risk score list can be used to predict the occurrence of delirium in patients admitted to inpatient hospice care, European Journal of Cancer Care 31(6).
- Nab, L.; Groenwold, R.H.H.; Klok, F.A.; Bhoelan, S.; Kruip, M.J.H.A. & Cannegieter, S.C. (2022), Estimating incidence of venous thromboembolism in COVID-19, Research and Practice in Thrombosis and Haemostasis 6(6).
- Zlei, M.; Sidorov, I.A.; Joosten, S.A.; Heemskerk, M.H.M.; Myeni, S.K.; Pothast, C.R.; Brouwer, C.S. de; Boomaars-van der Zanden, A.L.; Meijgaarden, K.E. van; Morales, S.T.; Wessels, E.; Janse, J.J.; Goeman, J.J.; Cobbaert, C.M.; Kroes, A.C.M.; Cannegieter, S.C.; Roestenberg, M.; Visser, L.G.; Kikkert, M.; Feltkamp, M.C.W.; Arbous, S.M.; Staal, F.J.T.; Ottenhoff, T.H.M.; Dongen, J.J.M. van; Roukens, A.H.E.; Vries, J.J.C. de; Collaboration BEAT-COVID & Collaboration LUMC COVID (2022), Immune determinants of viral clearance in hospitalised COVID-19 patients, Cells 11(17).
- Touw, C.E.; Nemeth, B.; Rondon, A.M.R.; Adrichem, R.A. van; Lisman, T.; Versteeg, H.H.; Schipper, I.B.; Nelissen, R.G.H.H.; Bos, M.H.A. & Cannegieter, S.C. (2022), Lower-leg injury and knee arthroscopy have distinct effects on coagulation, Blood Advances 6(17): 5232-5243.
- Piers, S.R.; Androulakis, A.F.; Yim, K.S.; Rein, N. van; Venlet, J.; Kapel, G.F.; Siebelink, H.M.; Lamb, H.J.; Cannegieter, S.C.; Man, S.C. & Zeppenfeld, K. (2022), Nonsustained ventricular tachycardia is independently associated with sustained ventricular arrhythmias in nonischemic dilated cardiomyopathy, Circulation: Arrhythmia and Electrophysiology 15(2): 114-125.
- Abdulrehman, J.; Elbaz, C.; Aziz, D.; Parpia, S.; Fazelzad, R.; Eischer, L.; Rodger, M.A.; Cannegieter, S.C.; Cate-Hoek, A. ten; Nagler, M.; Schulman, S.; Rezende, S.M.; Olie, V.; Palareti, G.; Marcucci, M.; Douketis, J.; Poli, D.; Zabczyk, M.; Sousa, D.A. de; Miranda, B.; Cushman, M.; Tosetto, A.; Gal, G. le; Kearon, C. & Skeith, L. (2022), Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis, British Journal of Haematology 199(1): 130-142.
- Scheres, L.J.J.; Vlieg, A.V. & Cannegieter, S.C. (2022), Sex-specific aspects of venous thromboembolism, Research and Practice in Thrombosis and Haemostasis 6(4).
- Toorop, M.M.A.; Rein, N. van; Nierman, M.C.; Vermaas, H.W.; Huisman, M.V.; Meer, F.J.M. van der; Cannegieter, S.C. & Lijfering, W.M. (2022), Inter- and intra-individual concentrations of direct oral anticoagulants, Journal of Thrombosis and Haemostasis 20(1): 92-103.
- Toorop, M.M.A.; Chen, Q.; Kruip, M.J.H.A.; Meer, F.J.M. van der; Nierman, M.C.; Faber, L.; Goede, L.; Cannegieter, S.C. & Lijfering, W.M. (2022), Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients, Journal of Thrombosis and Haemostasis 20(2): 339-352.
- Zielinski, G.D.; Rein, N. van; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Meer, F.J.M. van der; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2021), Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands, Pharmacoepidemiology & Drug Safety 30(8): 1027-1036.
- Paulsen, B.; Gran, O.V.; Severinsen, M.T.; Hammerstrom, J.; Kristensen, S.R.; Cannegieter, S.C.; Skille, H.; Tjonneland, A.; Rosendaal, F.R.; Overvad, K.; Naess, I.A.; Hansen, J.B. & Braekkan, S.K. (2021), Association of smoking and cancer with the risk of venous thromboembolism, Scientific Reports 11(1).
- Kaptein, F.H.J.; Stals, M.A M.; Grootenboers, M.; Braken, S.J.E.; Burggraaf, J.L.I.; Bussel, B.C.T. van; Cannegieter, S.C.; Cate, H. ten; Endeman, H.; Gommers, D.A.M.P.J.; Guldener, C. van; Jonge, E. de; Juffermans, N.P.; Kant, K.M.; Kevenaar, M.E.; Koster, S.; Kroft, L.J.M.; Kruip, M.J. H. A.; Leentjens, J.; Marechal, C.; Soei, Y.L.; Tjepkema, L.; Visser, C.; Klok, F.A. & Huisman, M.V. (2021), Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave, Thrombosis research 199.
- Kruip, M.J.H.A.; Cannegieter, S.C.; Cate, H. ten; Gorp, E.C.M. van; Juffermans, N.P.; Klok, F.A.; Maas, C.; Vonk-Noordegraaf, A. & Dutch COVID Thrombosis Coalition S (2021), Caging the dragon, Research and Practice in Thrombosis and Haemostasis 5(2): 278-291.
- Schenck, A.A.; Kruyt, J.M.; Benthem, P.P. van; Cannegieter, S.C.; Hout, W.B. van den; Bohringer, S.; Hammer, S.; Hombergen, S.P.M. & Blom, H.M. (2021), Effectiveness of endolymphatic duct blockage versus endolymphatic sac decompression in patients with intractable Meniere's disease, BMJ Open 11(8).
- Scheres, L.J.J.; Selier, N.L.D.; Nota, N.M.; Diemen, J.J.K. van; Cannegieter, S.C. & Heijer, M. den (2021), Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen, Journal of Thrombosis and Haemostasis 19(4): 1029-1037.
- Orsi, F.A.; Lijfering, W.M.; Geersing, G.J.; Rosendaal, F.R.; Dekkers, O.M.; Cessie, S. le & Cannegieter, S.C. (2021), Glucocorticoid use and risk of first and recurrent venous thromboembolism, British Journal of Haematology 193(6): 1194-1202.
- Zambelli, R.; Nemeth, B.; Touw, C.E.; Rosendaal, F.R.; Rezende, S.M. & Cannegieter, S.C. (2021), High risk of venous thromboembolism after orthopedic surgery in patients with thrombophilia, Journal of Thrombosis and Haemostasis.
- Krishnaswamy, S.; Ageno, W.; Arabi, Y.; Barbui, T.; Cannegieter, S.; Carrier, M.; Cleuren, A.C.; Collins, P.; Panicot-Dubois, L.; Freedman, J.E.; Freson, K.; Hogg, P.; James, A.H.; Kretz, C.A.; Lavin, M.; Leebeek, F.W.G.; Li, W.K.; Maas, C.; Machlus, K.; Makris, M.; Martinelli, I.; Medved, L.; Neerman-Arbez, M.; O'Donnell, J.S.; O'Sullivan, J.; Rajpurkar, M.; Schroeder, V.; Spiegel, P.C.; Stanworth, S.J.; Green, L. & Undas, A. (2021), Illustrated state-of-the-art capsules of the ISTH 2021 Congress, Research and Practice in Thrombosis and Haemostasis 5(5).
- Gademan, M.G.J.; Steenbergen, L.N. van; Cannegieter, S.C.; Nelissen, R.G.H.H. & Marang-Van de Mheen, P.J. (2021), Population-based 10-year cumulative revision risks after hip and knee arthroplasty for osteoarthritis to inform patients in clinical practice, Acta Orthopaedica 92(3).
- Biguzzi, E.; Castelli, F.; Lijfering, W.M.; Cannegieter, S.C.; Eikenboom, J.; Rosendaal, F.R. & Vlieg, A.V. (2021), Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 197: 172-178.
- Stals, M.A.M.; Grootenboers, M.J.J.H.; Guldener, C. van; Kaptein, F.H.J.; Braken, S.J.E.; Chen, Q.G.; Chu, G.; Driel, E.M. van; Sol, A.I. del; Jonge, E. de; Kant, K.M.; Pals, F.; Toorop, M.M.A.; Cannegieter, S.C.; Klok, F.A.; Huisman, M.V. & Dutch COVID Thrombosis Coalition (2021), Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients, Research and Practice in Thrombosis and Haemostasis 5(3): 412-420.
- Dronkers, C.E.A.; Hulle, T. van der; Gal, G. le; Kyrle, P.A.; Huisman, M.V.; Cannegieter, S.C. & Klok, F.A. (2021), Toward a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: Communication from the SSC of the ISTH.
- Toorop, M.M.A.; Chen, Q.G.; Tichelaar, V.Y.I.G.; Cannegieter, S.C. & Lijfering, W.M. (2021), Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation, European Heart Journal 42(40): 4126-+.
- Camilleri, E.; Rein, N. van; Meer, F.J.M. van der; Nierman, M.C.; Lijfering, W.M.; Cannegieter, S.C. & Dutch COVID Thrombosis Coalition (2021), Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis, Research and Practice in Thrombosis and Haemostasis 5(7).
- Toorop, M.M.A.; Rein, N. van; Cannegieter, S.C.; Meer, F.J.M. van der; Reitsma, P.H.; Lijfering, W.M. & Bos, M.H.A. (2021), High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case-Cohort Study, Thrombosis and Haemostasis 121(01): 70-75.
- Gent, J.A.N. van; Essen, T.A. van; Bos, M.H.A.; Cannegieter, S.C.; Dijck, J.T.J.M. van & Peul, W.C. (2020), Coagulopathy after hemorrhagic traumatic brain injury, an observational study of the incidence and prognosis, Acta Neurochirurgica 162(2): 329-336.
- Cannegieter, S.C. & Klok, F.A. (2020), COVID-19 associated coagulopathy and thromboembolic disease: commentary on an interim expert guidance, Research and Practice in Thrombosis and Haemostasis 4(4): 439-445.
- Adrichem, R.A. van; Nemeth, B.; Nelissen, R.G.H.H. & Cannegieter, S.C. (2020), No evidence for effective prevention of venous thromboembolism with low-molecular-weight heparin after anterior cruciate ligament reconstruction: letter to the editor.
- Chu, G.; Seelig, J.; Trinks-Roerdink, E.M.; Alem, A.P. van; Alings, M.; Bemt, B. van den; Boersma, L.V.A.; Brouwer, M.A.; Cannegieter, S.C.; Cate, H. ten; Kirchhof, C.J.H.J.; Crijns, H.J.G.M.; Dijk, E.J. van; Elvan, A.; Gelder, I.C. van; Groot, J.R. de; Hartog, F.R. den; Jong, J.S.S.G. de; Jong, S. de; Klok, F.A.; Lenderink, T.; Luermans, J.G.; Meeder, J.G.; Pisters, R.; Polak, P.; Rienstra, M.; Smeets, F.; Tahapary, G.J.M.; Theunissen, L.; Tieleman, R.G.; Trines, S.A.; Voort, P. van der; Geersing, G.J.; Rutten, F.H.; Hemels, M.E. & Huisman, M.V. (2020), Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation, BMJ Open 10(8).
- Timal, R.J.; Kooiman, J.; Sijpkens, Y.W.J.; Vries, J.P.P.M. de; Verberk-Jonkers, I.J.A.M.; Brulez, H.F.H.; Buren, M. van; Molen, A.J. van der; Cannegieter, S.C.; Putter, H.; Hout, W.B. van den; Jukema, J.W.; Rabelink, T.J. & Huisman, M.V. (2020), Effect of no prehydration vs sodium bicarbonate prehydration prior to contrast-enhanced computed tomography in the prevention of postcontrast acute kidney injury in adults with chronic kidney disease the Kompas randomized clinical trial, JAMA Internal Medicine 180(4): 533-541.
- Czuprynska, J.; Nemeth, B.; Roberts, L.N.; Cannegieter, S.C. & Arya, R. (2020), Thromboprophylaxis in temporary lower limb immobilization: extrapolate with care.
- Zielinski, G.D.; Rein, N. van; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Meer, F.J.M. van der; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2020), Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands, Research and Practice in Thrombosis and Haemostasis 4(1): 141-153.
- Morelli, V.M.; Mutsert, R. de; Roos, A. de; Lamb, H.J.; Vlieg, A.V.; Bos, M.H.A.; Rosendaal, F.R.; Lijfering, W.M. & Cannegieter, S.C. (2020), Association between hepatic triglyceride content and coagulation factors the Netherlands epidemiology of obesity study, Arteriosclerosis, Thrombosis, and Vascular Biology 40(12): 3004-3014.
- Bedene, A.; Dorp, E.L.A. van; Faquih, T.; Cannegieter, S.C.; Mook-Kanamori, D.O.; Niesters, M.; Velzen, M. van; Gademan, M.G.J.; Rosendaal, F.R.; Bouvy, M.L.; Dahan, A. & Lijfering, W.M. (2020), Causes and consequences of the opioid epidemic in the Netherlands, Scientific Reports 10(1).
- Dam, L.F. van; Kroft, L.J.M.; Wal, L.I. van der; Cannegieter, S.C.; Eikenboom, J.; Jonge, E. de; Huisman, M.V. & Klok, F.A. (2020), Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 193: 86-89.
- Zielinski, G.D.; Rein, N. van; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Meer, F.J.M. van der; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2020), Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands, Research and Practice in Thrombosis and Haemostasis 4(1): 141-153.
- Scheres, L.J.J.; Lijfering, W.M.; Groenewegen, N.F.M.; Koole, S.; Groot, C.J.M. de; Middeldorp, S. & Cannegieter, S.C. (2020), Hypertensive complications of pregnancy and risk of venous thromboembolism, Hypertension 75(3): 781-787.
- Lagerweij, G.R.; Brouwers, L.; Wit, G.A. de; Moons, K.G.M.; Benschop, L.; Maas, A.H.E.M.; Franx, A.; Wermer, M.J.H.; Lennep, J.E.R. van; Rijn, B.B. van; Koffijberg, H.; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Schouw, Y.T. van der; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zick, B.; Zoet, G.A. & CREW Consortium (2020), Impact of preventive screening and lifestyle interventions in women with a history of preeclampsia, European Journal of Preventive Cardiology 27(13): 1389-1399.
- Dam, L.F. van; Kroft, L.J.M.; Wal, L.I. van der; Cannegieter, S.C.; Eikenboom, J.; Jonge, E. de; Huisman, M.V. & Klok, F.A. (2020), More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
- Koopmans, R.J.; Cannegieter, S.C.; Koot, R. & Vleggeert-Lankamp, C.L.A. (2020), Nadroparin Plus Compression Stockings versus Nadroparin Alone for Prevention of Venous Thromboembolism in Cerebellopontine Angle Tumour Excisions: A Cohort Study, Thrombosis and Haemostasis 120(3): 525-530.
- Rokx, C.; Howard, J.F.B.; Smit, C.; Wit, F.W.; Pieterman, E.D.; Reiss, P.; Cannegieter, S.C.; Lijfering, W.M.; Meijer, K.; Bierman, W.; Tichelaar, V.; Rijnders, B.J.A. & ATHENA Observational HIV Cohort (2020), Risk of recurrent venous thromboembolism in patients with HIV infection, PLoS Medicine 17(5).
- Toorop, M.M.A.; Rein, N. van; Nierman, M.C.; Vermaas, H.W.; Huisman, M.V.; Meer, F.J.M. van der; Cannegieter, S.C. & Lijfering, W.M. (2020), Self-reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants, Research and Practice in Thrombosis and Haemostasis 4(4): 586-593.
- Toorop, M.M.A.; Rein, N. van; Nierman, M.C.; Vermaas, H.W.; Huisman, M.V.; Meer, F.J.M. van der; Cannegieter, S.C. & Lijfering, W.M. (2020), Switching from vitamin K antagonists to direct oral anticoagulants, Journal of Thrombosis and Haemostasis 18(6): 1390-1397.
- Buis, D.T.P.; Christen, T.; Smit, R.A.J.; Mutsert, R. de; Jukema, J.W.; Cannegieter, S.C.; Lijfering, W.M. & Rosendaal, F.R. (2020), The association between leptin concentration and blood coagulation, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 188: 44-48.
- Khialani, D.; Cessie, S. le; Lijfering, W.M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2020), The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk, British Journal of Haematology 191(1): 90-97.
- Bedene, A.; Dorp, E.L.A. van; Faquih, T.; Cannegieter, S.C.; Mook-Kanamori, D.O.; Niesters, M.; Velzen, M. van; Gademan, M.G.J.; Rosendaal, F.R.; Bouvy, M.L.; Dahan, A. & Lijfering, W.M. (2020), The opioid epidemic in the Netherlands, causes and consequences, Pharmacoepidemiology & Drug Safety 29: 201-202.
- Nemeth, B.; Nelissen, R.; Arya, R. & Cannegieter, S. (2020), Preventing VTE following total hip and knee arthroplasty, Journal of Thrombosis and Haemostasis 19(1).
- Rietveld, I.M.; Lijfering, W.M.; Cessie, S. le; Bos, M.H.A.; Rosendaal, F.R.; Reitsma, P.H. & Cannegieter, S.C. (2019), High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor, Journal of Thrombosis and Haemostasis 17(1): 99-109.
- Ende-Verhaar, Y.M.; Tick, L.W.; Klok, F.A.; Huisman, M.V.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Post-thrombotic syndrome: Short and long-term incidence and risk factors, Thrombosis Research 177: 102-109.
- Nemeth, B.; Adrichem, R. van; Nelissen, R.; Cessie, S. le & Cannegieter, S.C. (2019), Individualized Thromboprophylaxis in Patients with Lower-Leg Cast Immobilization-A Validation and Subgroup Analysis in the POT-CAST Trial, Thrombosis and Haemostasis 119(9): 1508-1516.
- Hensen, A.D.O.; Lijfering, W.M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2019), Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow-up study, British Journal of Haematology 187(2): 219-226.
- Scheres, L.J.J.; Vlieg, A.V.; Ballieux, B.E.P.B.; Fauser, B.C.J.M.; Rosendaal, F.R.; Middeldorp, S.; Cannegieter, S.C. & CREW Consortium (2019), Endogenous sex hormones and risk of venous thromboembolism in young women, Journal of Thrombosis and Haemostasis 17(8): 1297-1304.
- Gunning, M.N.; Meun, C.; Rijn, B.B. van; Maas, A.H.E.M.; Benschop, L.; Franx, A.; Boersma, E.; Budde, R.P.J.; Appelman, Y.; Lambalk, C.B.; Eijkemans, M.J.C.; Velthuis, B.K.; Laven, J.S.E.; Fauser, B.C.J.M.; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.; Cannegieter, S.; Dam, V.; Daan, N.; Eijkemans, R.; Fauser, B.; Ferrari, M.; Franx, A.; Groot, C. de; Gunning, M.; Hoek, A.; Koffijberg, E.; Koster, W.; Kruit, M.; Lagerweij, G.; Lambalk, N.; Laven, J.; Linstra, K.; Lugt, A. van der; Maas, A.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.; Rijn, B. van; Lennep, J.R. van; Roos-Hesselink, J.; Scheres, L.; Schouw, Y. van der; Steegers, E.; Steegers, R.; Terwindt, G.; Velthuis, B.; Wermer, M.; Zick, B.; Zoet, G. & CREW Consortium (2019), Coronary artery calcification in middle-aged women with premature ovarian insufficiency, Clinical Endocrinology 91(2): 314-322.
- Scheres, L.J.J.; Vlieg, A.V.; Ballieux, B.E.P.B.; Fauser, B.C.J.M.; Rosendaal, F.R.; Middeldorp, S.; Cannegieter, S.C. & CREW Consortium (2019), Endogenous sex hormones and risk of venous thromboembolism in young women, Journal of Thrombosis and Haemostasis 17(8): 1297-1304.
- Baart, S.J.; Dam, V.; Scheres, L.J.J.; Damen, J.A.A.G.; Spijker, R.; Schuit, E.; Debray, T.P.A.; Fauser, B.C.J.M.; Boersma, E.; Moons, K.G.M.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Schouw, Y.T. van der; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW Consortium (2019), Cardiovascular risk prediction models for women in the general population: A systematic review, PLoS ONE 14(1).
- Dam, V.; Onland-Moret, N.C.; Verschuren, W.M.M.; Boer, J.M.A.; Benschop, L.; Franx, A.; Moons, K.G.M.; Boersma, E.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW-Consortium (2019), Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy, Heart 105(4): 330-336.
- Orsi, F.A.; Lijfering, W.M.; Laarse, A. van der; Ruhaak, L.R.; Rosendaal, F.R.; Cannegieter, S.C. & Cobbaert, C. (2019), Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk, Clinical Epidemiology 11: 625-633.
- Visser, M. de; Bosch, J.; Bootsma, M.; Cannegieter, S.; Dijk, A. van; Heringhaus, C.; Nooij, J. de; Terpstra, N.; Peschanski, N. & Burggraaf, K. (2019), An observational study on survival rates of patients with out-of-hospital cardiac arrest in the Netherlands after improving the 'chain of survival', BMJ Open 9(7).
- Rietveld, I.M.; Lijfering, W.M.; Cessie, S. le; Bos, M.H.A.; Rosendaal, F.R.; Reitsma, P.H. & Cannegieter, S.C. (2019), High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor, Journal of Thrombosis and Haemostasis 17(1): 99-109.
- Orsi, F.A.; Lijfering, W.M.; Laarse, A. van der; Ruhaak, L.R.; Rosendaal, F.R.; Cannegieter, S.C. & Cobbaert, C. (2019), Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk, Clinical Epidemiology 11: 625-633.
- Dam, V.; Onland-Moret, N.C.; Verschuren, W.M.M.; Boer, J.M.A.; Benschop, L.; Franx, A.; Moons, K.G.M.; Boersma, E.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW-Consortium (2019), Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy, Heart 105(4): 330-336.
- Nemeth, B. & Cannegieter, S.C. (2019), Venous thrombosis following lower-leg cast immobilization and knee arthroscopy: From a population-based approach to individualized therapy, Thrombosis Research 174: 62-75.
- Douillet, D.; Nemeth, B.; Penaloza, A.; Gal, G. le; Moumneh, T.; Cannegieter, S.C. & Roy, P.M. (2019), Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization, PLoS ONE 14(6).
- Li-Gao, R.F.; Mook-Kanamori, D.O.; Cannegieter, S.C.; Dijk, K.W. van; Rosendaal, F.R. & Vlieg, A.V. (2019), The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis, Journal of Thrombosis and Haemostasis 17(9): 1535-1543.
- Cobben, M.R.R.; Nemeth, B.; Lijfering, W.M. & Cannegieter, S.C. (2019), Validation of risk assessment models for venous thrombosis in hospitalized medical patients, Research and Practice in Thrombosis and Haemostasis 3(2): 217-225.
- Li-Gao, R.F.; Mook-Kanamori, D.O.; Cannegieter, S.C.; Dijk, K.W. van; Rosendaal, F.R. & Vlieg, A.V. (2019), The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis, Journal of Thrombosis and Haemostasis 17(9): 1535-1543.
- Orsi, F.A.; Cannegieter, S.C. & Lijfering, W.M. (2019), Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review, Seminars in Thrombosis and Hemostasis 45(8): 825-833.
- Orsi, F.A.; Cannegieter, S.C. & Lijfering, W.M. (2019), Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review, Seminars in Thrombosis and Hemostasis 45(8): 825-833.
- Li-Gao, R.F.; Morelli, V.M.; Lijfering, W.M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2019), Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study, British Journal of Haematology 184(3): 431-435.
- Timp, J.F.; Lijfering, W.M.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Risk prediction of recurrent venous thrombosis; where are we now and what can we add?, Journal of Thrombosis and Haemostasis 17(9): 1527-1534.
- Orsi, F.A.; Biedermann, J.S.; Kruip, M.J.H.A.; Meer, F.J. van der; Rosendaal, F.R.; Vlieg, A.V.; Bos, M.H.A.; Leebeek, F.W.G.; Cannegieter, S.C. & Lijfering, W.M. (2019), Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial, Journal of Thrombosis and Haemostasis 17(2): 319-328.
- Timp, J.F.; Lijfering, W.M.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Risk prediction of recurrent venous thrombosis; where are we now and what can we add?, Journal of Thrombosis and Haemostasis 17(9): 1527-1534.
- Nemeth, B.; Lijfering, W.M.; Nelissen, R.G.H.H.; Schipper, I.B.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism, Jama Network Open 2(5).
- Timp, J.F.; Braekkan, S.K.; Lijfering, W.M.; Vlieg, A.V.; Hansen, J.B.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
- Lijfering, W.M.; Timp, J.F. & Cannegieter, S.C. (2019), Predicting the risk of recurrent venous thrombosis: What the future might bring, Journal of Thrombosis and Haemostasis 17(9): 1522-1526.
- Silvis, S.M.; Lindgren, E.; Hiltunen, S.; Devasagayam, S.; Scheres, L.J.; Jood, K.; Zuurbier, S.M.; Kleinig, T.J.; Silver, F.L.; Mandell, D.M.; Middeldorp, S.; Putaala, J.; Cannegieter, S.C.; Tatlisumak, T. & Coutinho, J.M. (2019), Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis A Case-Control Study, Stroke 50(2): 501-503.
- Dam, V.; Onland-Moret, N.C.; Verschuren, W.M.M.; Boer, J.M.A.; Benschop, L.; Franx, A.; Moons, K.G.M.; Boersma, E.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW-Consortium (2019), Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy, Heart 105(4): 330-336.
- Baart, S.J.; Dam, V.; Scheres, L.J.J.; Damen, J.A.A.G.; Spijker, R.; Schuit, E.; Debray, T.P.A.; Fauser, B.C.J.M.; Boersma, E.; Moons, K.G.M.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Schouw, Y.T. van der; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW Consortium (2019), Cardiovascular risk prediction models for women in the general population: A systematic review, PLoS ONE 14(1).
- Li-Gao, R.F.; Morelli, V.M.; Lijfering, W.M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2019), Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case-control study, British Journal of Haematology 184(3): 431-435.
- Rein, N. van; Heide-Jorgensen, U.; Lijfering, W.M.; Dekkers, O.M.; Sorensen, H.T. & Cannegieter, S.C. (2019), Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy Results From a Nationwide Danish Cohort Study, Circulation 139(6): 775-786.
- Silvis, S.M.; Lindgren, E.; Hiltunen, S.; Devasagayam, S.; Scheres, L.J.; Jood, K.; Zuurbier, S.M.; Kleinig, T.J.; Silver, F.L.; Mandell, D.M.; Middeldorp, S.; Putaala, J.; Cannegieter, S.C.; Tatlisumak, T. & Coutinho, J.M. (2019), Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis A Case-Control Study, Stroke 50(2): 501-503.
- Ende-Verhaar, Y.M.; Tick, L.W.; Klok, F.A.; Huisman, M.V.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Post-thrombotic syndrome: Short and long-term incidence and risk factors, Thrombosis Research 177: 102-109.
- Orsi, F.A.; Biedermann, J.S.; Kruip, M.J.H.A.; Meer, F.J. van der; Rosendaal, F.R.; Vlieg, A.V.; Bos, M.H.A.; Leebeek, F.W.G.; Cannegieter, S.C. & Lijfering, W.M. (2019), Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial, Journal of Thrombosis and Haemostasis 17(2): 319-328.
- Cobben, M.R.R.; Nemeth, B.; Lijfering, W.M. & Cannegieter, S.C. (2019), Validation of risk assessment models for venous thrombosis in hospitalized medical patients, Research and Practice in Thrombosis and Haemostasis 3(2): 217-225.
- Nemeth, B. & Cannegieter, S.C. (2019), Venous thrombosis following lower-leg cast immobilization and knee arthroscopy: From a population-based approach to individualized therapy, Thrombosis Research 174: 62-75.
- Rein, N. van; Heide-Jorgensen, U.; Lijfering, W.M.; Dekkers, O.M.; Sorensen, H.T. & Cannegieter, S.C. (2019), Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy Results From a Nationwide Danish Cohort Study, Circulation 139(6): 775-786.
- Timp, J.F.; Braekkan, S.K.; Lijfering, W.M.; Vlieg, A.V.; Hansen, J.B.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
- Lijfering, W.M.; Timp, J.F. & Cannegieter, S.C. (2019), Predicting the risk of recurrent venous thrombosis: What the future might bring, Journal of Thrombosis and Haemostasis 17(9): 1522-1526.
- Gunning, M.N.; Meun, C.; Rijn, B.B. van; Maas, A.H.E.M.; Benschop, L.; Franx, A.; Boersma, E.; Budde, R.P.J.; Appelman, Y.; Lambalk, C.B.; Eijkemans, M.J.C.; Velthuis, B.K.; Laven, J.S.E.; Fauser, B.C.J.M.; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.; Cannegieter, S.; Dam, V.; Daan, N.; Eijkemans, R.; Fauser, B.; Ferrari, M.; Franx, A.; Groot, C. de; Gunning, M.; Hoek, A.; Koffijberg, E.; Koster, W.; Kruit, M.; Lagerweij, G.; Lambalk, N.; Laven, J.; Linstra, K.; Lugt, A. van der; Maas, A.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.; Rijn, B. van; Lennep, J.R. van; Roos-Hesselink, J.; Scheres, L.; Schouw, Y. van der; Steegers, E.; Steegers, R.; Terwindt, G.; Velthuis, B.; Wermer, M.; Zick, B.; Zoet, G. & CREW Consortium (2019), Coronary artery calcification in middle-aged women with premature ovarian insufficiency, Clinical Endocrinology 91(2): 314-322.
- Dam, V.; Onland-Moret, N.C.; Verschuren, W.M.M.; Boer, J.M.A.; Benschop, L.; Franx, A.; Moons, K.G.M.; Boersma, E.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW-Consortium (2019), Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy, Heart 105(4): 330-336.
- Baart, S.J.; Dam, V.; Scheres, L.J.J.; Damen, J.A.A.G.; Spijker, R.; Schuit, E.; Debray, T.P.A.; Fauser, B.C.J.M.; Boersma, E.; Moons, K.G.M.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Schouw, Y.T. van der; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW Consortium (2019), Cardiovascular risk prediction models for women in the general population: A systematic review, PLoS ONE 14(1).
- Douillet, D.; Nemeth, B.; Penaloza, A.; Gal, G. le; Moumneh, T.; Cannegieter, S.C. & Roy, P.M. (2019), Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization, PLoS ONE 14(6).
- Nemeth, B.; Lijfering, W.M.; Nelissen, R.G.H.H.; Schipper, I.B.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism, Jama Network Open 2(5).
- Lijfering, W.M. & Cannegieter, S.C. (2019), Nutrition and venous thrombosis: An exercise in thinking about survivor bias, Research and Practice in Thrombosis and Haemostasis 3(1): 6-8.
- Hensen, A.D.O.; Lijfering, W.M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2019), Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow-up study, British Journal of Haematology 187(2): 219-226.
- Nemeth, B.; Adrichem, R. van; Nelissen, R.; Cessie, S. le & Cannegieter, S.C. (2019), Individualized Thromboprophylaxis in Patients with Lower-Leg Cast Immobilization-A Validation and Subgroup Analysis in the POT-CAST Trial, Thrombosis and Haemostasis 119(9): 1508-1516.
- Lijfering, W.M. & Cannegieter, S.C. (2019), Nutrition and venous thrombosis: An exercise in thinking about survivor bias, Research and Practice in Thrombosis and Haemostasis 3(1): 6-8.
- Baart, S.J.; Dam, V.; Scheres, L.J.J.; Damen, J.A.A.G.; Spijker, R.; Schuit, E.; Debray, T.P.A.; Fauser, B.C.J.M.; Boersma, E.; Moons, K.G.M.; Schouw, Y.T. van der; Appelman, Y.; Baart, S.; Benschop, L.; Boersma, E.; Brouwers, L.; Budde, R.P.J.; Cannegieter, S.C.; Dam, V.; Eijkemans, R.M.J.C.; Fauser, B.C.J.M.; Ferrari, M.D.; Franx, A.; Groot, C.J.M. de; Gunning, M.N.; Hoek, A.; Koffijberg, H.; Koster, M.P.H.; Kruit, M.C.; Lagerweij, G.R.; Lambalk, C.B.; Laven, J.S.E.; Linstra, K.M.; Lugt, A. van der; Maas, A.H.E.M.; Brink, A.M. van den; Meun, C.; Middeldorp, S.; Moons, K.G.M.; Rijn, B.B. van; Lennep, J.E.R. van; Roos-Hesselink, J.W.; Scheres, L.J.J.; Schouw, Y.T. van der; Steegers, E.A.P.; Steegers-Theunissen, R.P.M.; Terwindt, G.M.; Velthuis, B.K.; Wermer, M.J.H.; Zoet, G.A. & CREW Consortium (2019), Cardiovascular risk prediction models for women in the general population: A systematic review, PLoS ONE 14(1).
- Rietveld, I.M.; Bos, M.H.A.; Lijfering, W.M.; Li-Gao, R.F.; Rosendaal, F.R.; Reitsma, P.H. & Cannegieter, S.C. (2018), Factor V levels and risk of venous thrombosis: The MEGA case-control study, Research and Practice in Thrombosis and Haemostasis 2(2): 320-326.
- Dronkers, C.E.A.; Lijfering, W.M.; Teichert, M.; Meer, F.J.M. van der; Klok, F.A.; Cannegieter, S.C. & Huisman, M.V. (2018), Persistence to direct oral anticoagulants for acute venous thromboembolism, Thrombosis Research 167: 135-141.
- Silvis, S.M.; Hiltunen, S.; Lindgren, E.; Jood, K.; Zuurbier, S.M.; Middeldorp, S.; Putaala, J.; Cannegieter, S.C.; Tatlisumak, T. & Coutinho, J.M. (2018), Cancer and risk of cerebral venous thrombosis: a case-control study, Journal of Thrombosis and Haemostasis 16(1): 90-95.
- Scheres, L.J.J.; Lijfering, W.M. & Cannegieter, S.C. (2018), Current and future burden of venous thrombosis: Not simply predictable, Research and Practice in Thrombosis and Haemostasis 2(2): 199-208.
- Unlu, B.; Es, N. van; Arindrarto, W.; Kielbasa, S.M.; Mei, H.; Westerga, J.; Middeldorp, S.; Kuppen, P.J.K.; Otten, J.M.M.B.; Cannegieter, S. & Versteeg, H.H. (2018), Genes associated with venous thromboembolism in colorectal cancer patients, Journal of Thrombosis and Haemostasis 16(2): 293-302.
- Huisman, M.V.; Barco, S.; Cannegieter, S.C.; Gal, G. le; Konstantinides, S.V.; Reitsma, P.H.; Rodger, M.; Noordegraaf, A.V. & Klok, F.A. (2018), Pulmonary embolism, Nature Reviews Disease Primers 4.
- Gademan, M.G.J.; Putter, H.; Hout, W.B. van den; Kloppenburg, M.; Hofstede, S.N.; Cannegieter, S.C.; Nelissen, R.G.H.H. & Marang-Van De Mheen, P.J. (2018), The course of pain and function in osteoarthritis and timing of arthroplasty: the CHECK cohort, Acta Orthopaedica 89(5): 528-534.
- Rein, N. van; Geus, K.S. de; Cannegieter, S.C.; Reitsma, P.H.; Meer, F.J.M. van der & Lijfering, W.M. (2018), Multi-dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists, Pharmacoepidemiology and Drug Safety 27(1): 46-51.
- Unlu, B.; Es, N. van; Arindrarto, W.; Kielbasa, S.M.; Mei, H.; Westerga, J.; Middeldorp, S.; Kuppen, P.J.K.; Otten, J.M.M.B.; Cannegieter, S. & Versteeg, H.H. (2018), Genes associated with venous thromboembolism in colorectal cancer patients, Journal of Thrombosis and Haemostasis 16(2): 293-302.
- Eindhoven, D.C.; Staveren, L.N. van; Erkelens, J.A. van; Ikkersheim, D.E.; Cannegieter, S.C.; Umans, V.A.W.M.; Mosterd, A.; Wijngaarden, J. van; Schalij, M.J. & Borleffs, C.J.W. (2018), Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands, Netherlands Heart Journal 26(1): 13-19.
- Dronkers, C.E.A.; Lijfering, W.M.; Teichert, M.; Meer, F.J.M. van der; Klok, F.A.; Cannegieter, S.C. & Huisman, M.V. (2018), Persistence to direct oral anticoagulants for acute venous thromboembolism, Thrombosis Research 167: 135-141.
- Dekkers, I.A.; Mutsert, R. de; Vries, A.P.J. de; Rosendaal, F.R.; Cannegieter, S.C.; Jukema, J.W.; Cessie, S. le; Rabelink, T.J.; Lamb, H.J. & Lijfering, W.M. (2018), Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population, Journal of Thrombosis and Haemostasis 16(3): 519-528.
- Sokol, J.; Timp, J.F.; Cessie, S. le; Hylckama-Vlieg, A. van; Rosendaal, F.R.; Kubisz, P.; Cannegieter, S.C. & Lijfering, W.M. (2018), Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study, Journal of Thrombosis and Haemostasis 16(4): 680-688.
- Nemeth, B.; Adrichem, R.A. van; Vlieg, A.V.; Baglin, T.; Rosendaal, F.R.; Nelissen, R.G.H.H.; Cessie, S. le & Cannegieter, S.C. (2018), Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score, Thrombosis and Haemostasis 118(10): 1823-1831.
- Dekker, L.; Geraedts, V.J.; Hund, H.; Cannegieter, S.C.; Nogueira, R.G.; Goyal, M. & Wijngaard, I.R. van den (2018), Importance of Reperfusion Status after Intra-Arterial Thrombectomy for Prediction of Outcome in Anterior Circulation Large Vessel Stroke, Interventional Neurology 7(3-4): 137-147.
- Zielinski, G.D.; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2018), Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints, Pharmacoepidemiology and Drug Safety 27(12): 1371-1378.
- Rietveld, I.M.; Bos, M.H.A.; Lijfering, W.M.; Li-Gao, R.F.; Rosendaal, F.R.; Reitsma, P.H. & Cannegieter, S.C. (2018), Factor V levels and risk of venous thrombosis: The MEGA case-control study, Research and Practice in Thrombosis and Haemostasis 2(2): 320-326.
- Biedermann, J.S.; Kruip, M.J.H.A.; Meer, F.J. van der; Rosendaal, F.R.; Leebeek, F.W.G.; Cannegieter, S.C. & Lijfering, W.M. (2018), Rosuvastatin use improvesmeasures of coagulation in patients with venous thrombosis, European Heart Journal 39(19): 1740-1747.
- Silvis, S.M.; Hiltunen, S.; Lindgren, E.; Jood, K.; Zuurbier, S.M.; Middeldorp, S.; Putaala, J.; Cannegieter, S.C.; Tatlisumak, T. & Coutinho, J.M. (2018), Cancer and risk of cerebral venous thrombosis: a case-control study, Journal of Thrombosis and Haemostasis 16(1): 90-95.
- Scheres, L.J.J.; Lijfering, W.M. & Cannegieter, S.C. (2018), Current and future burden of venous thrombosis: Not simply predictable, Research and Practice in Thrombosis and Haemostasis 2(2): 199-208.
- Wall, S.J. van der; Pol, L.M. van der; Ende-Verhaar, Y.M.; Cannegieter, S.C.; Schulman, S.; Prandoni, P.; Rodger, M.; Huisman, M.V. & Klok, F.A. (2018), Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review, European Respiratory Review 27(150).
- Ospina-Romero, M.; Cannegieter, S.C.; Heijer, M. den; Doggen, C.J.M.; Rosendaal, F.R. & Lijfering, W.M. (2018), Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors, American Journal of Epidemiology 187(7): 1392-1400.
- Blix, K.; Gran, O.V.; Severinsen, M.T.; Cannegieter, S.C.; Jensvoll, H.; Overvad, K.; Hammerstrom, J.; Tjonneland, A.; Naess, I.A.; Braekkan, S.K.; Rosendaal, F.R.; Kristensen, S.R. & Hansen, J.B. (2018), Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort, Journal of Thrombosis and Haemostasis 16(7): 1327-1335.
- Scheres, L.J.J.; Lijfering, W.M.; Middeldorp, S.; Cheung, Y.W.; Barco, S.; Cannegieter, S.C. & Coppens, M. (2018), Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials, Research and Practice in Thrombosis and Haemostasis 2(4): 689-695.
- Morelli, V.M.; Lijfering, W.M.; Rezende, S.M.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2018), Role of Routine Laboratory Tests in Assessing Risk of Recurrent Venous Thrombosis: Results from the MEGA Follow-Up Study, Thrombosis and Haemostasis 118(11): 1918-1929.
- Elbers, L.P.B.; Fliers, E. & Cannegieter, S.C. (2018), The influence of thyroid function on the coagulation system and its clinical consequences, Journal of Thrombosis and Haemostasis 16(4): 634-645.
- Nemeth, B.; Timp, J.F.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2018), High risk of recurrent venous thrombosis in patients with lower-leg cast immobilization, Journal of Thrombosis and Haemostasis 16(11): 2218-2222.
- Eindhoven, D.C.; Wu, H.W.; Kremer, S.W.F.; Erkelens, J.A. van; Cannegieter, S.C.; Schalij, M.J. & Borleffs, C.J.W. (2018), Mortality differences in acute myocardial infarction patients in the Netherlands: The weekend-effect, American Heart Journal 205: 70-76.
- Horvath-Puho, E.; Suttorp, M.M.; Frederiksen, H.; Hoekstra, T.; Dekkers, O.M.; Pedersen, L.; Cannegieter, S.C.; Dekker, F.W. & Sorensen, H.T. (2018), Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma, Clinical Epidemiology 10: 1371-1380.
- Christensen, D.H.; Veres, K.; Ording, A.G.; Jorgensen, J.O.L.; Cannegieter, S.C.; Thomsen, R.W. & Sorensen, H.T. (2018), Risk of cancer in patients with thyroid disease and venous thromboembolism, Clinical Epidemiology 10: 907-915.
- Kooiman, J.; Vries, J.P.P.M. de; Heyden, J. van der; Sijpkens, Y.W.J.; Dijkman, P.R.M. van; Wever, J.J.; Overhagen, H. van; Vahl, A.C.; Aarts, N.; Verberk-Jonkers, I.J.A.M.; Brulez, H.F.H.; Hamming, J.F.; Molen, A.J. van der; Cannegieter, S.C.; Putter, H.; Hout, W.B. van den; Kilicsoy, I.; Rabelink, T.J. & Huisman, M.V. (2018), Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures, PLoS ONE 13(2).
- Biedermann, J.S.; Kruip, M.J.H.A.; Meer, F.J. van der; Rosendaal, F.R.; Leebeek, F.W.G.; Cannegieter, S.C. & Lijfering, W.M. (2018), Rosuvastatin use improvesmeasures of coagulation in patients with venous thrombosis, European Heart Journal 39(19): 1740-1747.
- Dekkers, I.A.; Mutsert, R. de; Vries, A.P.J. de; Rosendaal, F.R.; Cannegieter, S.C.; Jukema, J.W.; Cessie, S. le; Rabelink, T.J.; Lamb, H.J. & Lijfering, W.M. (2018), Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population, Journal of Thrombosis and Haemostasis 16(3): 519-528.
- Wall, S.J. van der; Pol, L.M. van der; Ende-Verhaar, Y.M.; Cannegieter, S.C.; Schulman, S.; Prandoni, P.; Rodger, M.; Huisman, M.V. & Klok, F.A. (2018), Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review, European Respiratory Review 27(150).
- Christensen, D.H.; Veres, K.; Ording, A.G.; Jorgensen, J.O.L.; Cannegieter, S.C.; Thomsen, R.W. & Sorensen, H.T. (2018), Risk of cancer in patients with thyroid disease and venous thromboembolism, Clinical Epidemiology 10: 907-915.
- Nemeth, B.; Adrichem, R.A. van; Vlieg, A.V.; Baglin, T.; Rosendaal, F.R.; Nelissen, R.G.H.H.; Cessie, S. le & Cannegieter, S.C. (2018), Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score, Thrombosis and Haemostasis 118(10): 1823-1831.
- Horvath-Puho, E.; Suttorp, M.M.; Frederiksen, H.; Hoekstra, T.; Dekkers, O.M.; Pedersen, L.; Cannegieter, S.C.; Dekker, F.W. & Sorensen, H.T. (2018), Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma, Clinical Epidemiology 10: 1371-1380.
- Ospina-Romero, M.; Cannegieter, S.C.; Heijer, M. den; Doggen, C.J.M.; Rosendaal, F.R. & Lijfering, W.M. (2018), Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors, American Journal of Epidemiology 187(7): 1392-1400.
- Blix, K.; Gran, O.V.; Severinsen, M.T.; Cannegieter, S.C.; Jensvoll, H.; Overvad, K.; Hammerstrom, J.; Tjonneland, A.; Naess, I.A.; Braekkan, S.K.; Rosendaal, F.R.; Kristensen, S.R. & Hansen, J.B. (2018), Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort, Journal of Thrombosis and Haemostasis 16(7): 1327-1335.
- Dekker, L.; Geraedts, V.J.; Hund, H.; Cannegieter, S.C.; Nogueira, R.G.; Goyal, M. & Wijngaard, I.R. van den (2018), Importance of Reperfusion Status after Intra-Arterial Thrombectomy for Prediction of Outcome in Anterior Circulation Large Vessel Stroke, Interventional Neurology 7(3-4): 137-147.
- Scheres, L.J.J.; Lijfering, W.M.; Middeldorp, S.; Cheung, Y.W.; Barco, S.; Cannegieter, S.C. & Coppens, M. (2018), Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials, Research and Practice in Thrombosis and Haemostasis 2(4): 689-695.
- Zielinski, G.D.; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2018), Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints, Pharmacoepidemiology and Drug Safety 27(12): 1371-1378.
- Sokol, J.; Timp, J.F.; Cessie, S. le; Hylckama-Vlieg, A. van; Rosendaal, F.R.; Kubisz, P.; Cannegieter, S.C. & Lijfering, W.M. (2018), Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study, Journal of Thrombosis and Haemostasis 16(4): 680-688.
- Eindhoven, D.C.; Staveren, L.N. van; Erkelens, J.A. van; Ikkersheim, D.E.; Cannegieter, S.C.; Umans, V.A.W.M.; Mosterd, A.; Wijngaarden, J. van; Schalij, M.J. & Borleffs, C.J.W. (2018), Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands, Netherlands Heart Journal 26(1): 13-19.
- Morelli, V.M.; Lijfering, W.M.; Rezende, S.M.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2018), Role of Routine Laboratory Tests in Assessing Risk of Recurrent Venous Thrombosis: Results from the MEGA Follow-Up Study, Thrombosis and Haemostasis 118(11): 1918-1929.
- Elbers, L.P.B.; Fliers, E. & Cannegieter, S.C. (2018), The influence of thyroid function on the coagulation system and its clinical consequences, Journal of Thrombosis and Haemostasis 16(4): 634-645.
- Rein, N. van; Geus, K.S. de; Cannegieter, S.C.; Reitsma, P.H.; Meer, F.J.M. van der & Lijfering, W.M. (2018), Multi-dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists, Pharmacoepidemiology and Drug Safety 27(1): 46-51.
- Kooiman, J.; Vries, J.P.P.M. de; Heyden, J. van der; Sijpkens, Y.W.J.; Dijkman, P.R.M. van; Wever, J.J.; Overhagen, H. van; Vahl, A.C.; Aarts, N.; Verberk-Jonkers, I.J.A.M.; Brulez, H.F.H.; Hamming, J.F.; Molen, A.J. van der; Cannegieter, S.C.; Putter, H.; Hout, W.B. van den; Kilicsoy, I.; Rabelink, T.J. & Huisman, M.V. (2018), Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures, PLoS ONE 13(2).
- Nemeth, B.; Timp, J.F.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2018), High risk of recurrent venous thrombosis in patients with lower-leg cast immobilization, Journal of Thrombosis and Haemostasis 16(11): 2218-2222.
- Eindhoven, D.C.; Wu, H.W.; Kremer, S.W.F.; Erkelens, J.A. van; Cannegieter, S.C.; Schalij, M.J. & Borleffs, C.J.W. (2018), Mortality differences in acute myocardial infarction patients in the Netherlands: The weekend-effect, American Heart Journal 205: 70-76.
- Timp, J.F.; Cannegieter, S.C.; Tichelaar, V.; Braekkan, S.K.; Rosendaal, F.R.; Cessie, S. & Lijfering, W.M. (2017), Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis, British Journal of Haematology 176(6): 961-970.
- Dekkers, O.M.; Horvath-Puho, E.; Cannegieter, S.C.; Vandenbroucke, J.P.; Sorensen, H.T. & Jorgensen, J.O.L. (2017), Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study, European Journal of Endocrinology 176(1): 1-9.
- Heijden, A.C. van der; Rees, J.B. van; Levy, W.C.; Bom, J.G. van der; Cannegieter, S.C.; Bie, M.K. de; Erven, L. van; Schalij, M.J. & Borleffs, C.J.W. (2017), Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment, EP-Europace 19(1): 72-80.
- Mahmoodi, B.K.; Cushman, M.; Naess, I.A.; Allison, M.A.; Bos, W.J.; Braekkan, S.K.; Cannegieter, S.C.; Gansevoort, R.T.; Gona, P.N.; Hammerstrom, J.; Hansen, J.B.; Heckbert, S.; Holst, A.G.; Lakoski, S.G.; Lutsey, P.L.; Manson, J.E.; Martin, L.W.; Matsushita, K.; Meijer, K.; Overvad, K.; Prescott, E.; Puurunen, M.; Rossouw, J.E.; Sang, Y.Y.; Severinsen, M.T.; Berg, J. ten; Folsom, A.R. & Zakai, N.A. (2017), Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism An Individual Participant Data Meta-Analysis of Prospective Studies, Circulation 135(1): 7-+.
- Wall, S.J. van der; Klok, F.A.; Exter, P.L. den; Barrios, D.; Morillo, R.; Cannegieter, S.C.; Jimenez, D. & Huisman, M.V. (2017), Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice, Journal of Thrombosis and Haemostasis 15(1): 74-79.
- Dronkers, C.E.A.; Ende-Verhaar, Y.M.; Kyrle, P.A.; Righini, M.; Cannegieter, S.C.; Huisman, M.V.; Klok, F.A. & Subcomm Predictive Diag Variables (2017), Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis 15(11): 2270-2273.
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2017), Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature, European Respiratory Journal 49(2).
- Rein, N. van; Biedermann, J.S.; Meer, F.J.M. van der; Cannegieter, S.C.; Wiersma, N.; Vermaas, H.W.; Reitsma, P.H.; Kruip, M.J.H.A. & Lijfering, W.M. (2017), Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis, Journal of Thrombosis and Haemostasis 15(7): 1386-1391.
- Meessen, J.M.T.A.; Peter, W.F.; Wolterbeek, R.; Cannegieter, S.C.; Tilbury, C.; Benard, M.R.; Linden, H.M.J. van der; Onstenk, R.; Tordoir, R.; Vehmeijer, S.B.; Verdegaal, S.H.M.; Vermeulen, H.M.; Nelissen, R.G.H.H. & Vlieland, T.P.M.V. (2017), Patients who underwent total hip or knee arthroplasty are more physically active than the general Dutch population, Rheumatology International 37(2): 219-227.
- Kort, D.; Rein, N. van; Meer, F.J.M. van der; Vermaas, H.W.; Wiersma, N.; Cannegieter, S.C. & Lijfering, W.M. (2017), Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study, Journal of Thrombosis and Haemostasis 15(12): 2352-2360.
- Scheres, L.J.J.; Brekelmans, M.P.A.; Beenen, L.F.M.; Buller, H.R.; Cannegieter, S.C. & Middeldorp, S. (2017), Sex-specific differences in the presenting location of a first venous thromboembolism, Journal of Thrombosis and Haemostasis 15(7): 1344-1350.
- Gade, I.L.; Braekkan, S.K.; Naess, I.A.; Hansen, J.B.; Cannegieter, S.C.; Overvad, K.; Jensvoll, H.; Hammerstrom, J.; Blix, K.; Tjonneland, A.; Kristensen, S.R. & Severinsen, M.T. (2017), The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort, Journal of Thrombosis and Haemostasis 15(8): 1567-1575.
- Dronkers, C.E.A.; Hulle, T. van der; Gal, G. le; Kyrle, P.A.; Huisman, M.V.; Cannegieter, S.C.; Klok, F.A. & Subcomm Predictive Diagnost (2017), Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis 15(5): 1040-1043.
- Nemeth, B. & Cannegieter, S.C. (2017), Cast immobilization of the lower-leg: No indication for thromboprophylactic therapy, Injury 48(12): 2887-2888.
- Rozemeijer, K.; Cessie, S. le; Vlieg, A.V.; Rosendaal, F.R.; Vandenbroucke, J.P.; Poole, C. & Cannegieter, S.C. (2017), Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors, American Journal of Epidemiology 185(10): 965-973.
- Heijden, A.C. van der; Rees, J.B. van; Levy, W.C.; Bom, J.G. van der; Cannegieter, S.C.; Bie, M.K. de; Erven, L. van; Schalij, M.J. & Borleffs, C.J.W. (2017), Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment, EP-Europace 19(1): 72-80.
- Scheres, L.J.J.; Brekelmans, M.P.A.; Beenen, L.F.M.; Buller, H.R.; Cannegieter, S.C. & Middeldorp, S. (2017), Sex-specific differences in the presenting location of a first venous thromboembolism, Journal of Thrombosis and Haemostasis 15(7): 1344-1350.
- Wall, S.J. van der; Klok, F.A.; Exter, P.L. den; Barrios, D.; Morillo, R.; Cannegieter, S.C.; Jimenez, D. & Huisman, M.V. (2017), Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice, Journal of Thrombosis and Haemostasis 15(1): 74-79.
- Timp, J.F.; Cannegieter, S.C.; Tichelaar, V.; Braekkan, S.K.; Rosendaal, F.R.; Cessie, S. & Lijfering, W.M. (2017), Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis, British Journal of Haematology 176(6): 961-970.
- Mahmoodi, B.K.; Cushman, M.; Naess, I.A.; Allison, M.A.; Bos, W.J.; Braekkan, S.K.; Cannegieter, S.C.; Gansevoort, R.T.; Gona, P.N.; Hammerstrom, J.; Hansen, J.B.; Heckbert, S.; Holst, A.G.; Lakoski, S.G.; Lutsey, P.L.; Manson, J.E.; Martin, L.W.; Matsushita, K.; Meijer, K.; Overvad, K.; Prescott, E.; Puurunen, M.; Rossouw, J.E.; Sang, Y.Y.; Severinsen, M.T.; Berg, J. ten; Folsom, A.R. & Zakai, N.A. (2017), Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism An Individual Participant Data Meta-Analysis of Prospective Studies, Circulation 135(1): 7-+.
- Gade, I.L.; Braekkan, S.K.; Naess, I.A.; Hansen, J.B.; Cannegieter, S.C.; Overvad, K.; Jensvoll, H.; Hammerstrom, J.; Blix, K.; Tjonneland, A.; Kristensen, S.R. & Severinsen, M.T. (2017), The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort, Journal of Thrombosis and Haemostasis 15(8): 1567-1575.
- Gade, I.L.; Braekkan, S.; Naess, I.A.; Hansen, J.B.; Rosendaal, F.; Cannegieter, S.; Overvad, K.; Jensvoll, H.; Hammerstrom, J.; Gran, O.V.; Tjonneland, A.; Kristensen, S.R. & Severinsen, M.T. (2017), Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort, Thrombosis Research 158: 157-160.
- Dronkers, C.E.A.; Ende-Verhaar, Y.M.; Kyrle, P.A.; Righini, M.; Cannegieter, S.C.; Huisman, M.V.; Klok, F.A. & Subcomm Predictive Diag Variables (2017), Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis 15(11): 2270-2273.
- Rein, N. van; Biedermann, J.S.; Meer, F.J.M. van der; Cannegieter, S.C.; Wiersma, N.; Vermaas, H.W.; Reitsma, P.H.; Kruip, M.J.H.A. & Lijfering, W.M. (2017), Major bleeding risks of different low-molecular-weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis, Journal of Thrombosis and Haemostasis 15(7): 1386-1391.
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2017), Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature, European Respiratory Journal 49(2).
- Adrichem, R.A. van; Nemeth, B.; Algra, A.; Cessie, S. le; Rosendaal, F.R.; Schipper, I.B.; Nelissen, R.G.H.H.; Cannegieter, S.C. & POT-KAST POT-CAST Grp (2017), Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting, New England Journal of Medicine 376(6): 515-525.
- Vuckovic, B.A.; Cannegieter, S.C.; Vlieg, A.V.; Rosendaal, F.R. & Lijfering, W.M. (2017), Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow-up study, Journal of Thrombosis and Haemostasis 15(7): 1430-1435.
- Meessen, J.M.T.A.; Peter, W.F.; Wolterbeek, R.; Cannegieter, S.C.; Tilbury, C.; Benard, M.R.; Linden, H.M.J. van der; Onstenk, R.; Tordoir, R.; Vehmeijer, S.B.; Verdegaal, S.H.M.; Vermeulen, H.M.; Nelissen, R.G.H.H. & Vlieland, T.P.M.V. (2017), Patients who underwent total hip or knee arthroplasty are more physically active than the general Dutch population, Rheumatology International 37(2): 219-227.
- Dekkers, O.M.; Horvath-Puho, E.; Cannegieter, S.C.; Vandenbroucke, J.P.; Sorensen, H.T. & Jorgensen, J.O.L. (2017), Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study, European Journal of Endocrinology 176(1): 1-9.
- Dronkers, C.E.A.; Hulle, T. van der; Gal, G. le; Kyrle, P.A.; Huisman, M.V.; Cannegieter, S.C.; Klok, F.A. & Subcomm Predictive Diagnost (2017), Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis 15(5): 1040-1043.
- Kort, D.; Rein, N. van; Meer, F.J.M. van der; Vermaas, H.W.; Wiersma, N.; Cannegieter, S.C. & Lijfering, W.M. (2017), Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study, Journal of Thrombosis and Haemostasis 15(12): 2352-2360.
- Morelli, V.M.; Lijfering, W.M.; Bos, M.H.A.; Rosendaal, F.R. & Cannegieter, S.C. (2017), Lipid levels and risk of venous thrombosis: results from the MEGA-study, European Journal of Epidemiology 32(8): 669-681.
- Adrichem, R.A. van; Nemeth, B.; Algra, A.; Cessie, S. le; Rosendaal, F.R.; Schipper, I.B.; Nelissen, R.G.H.H.; Cannegieter, S.C. & POT-KAST POT-CAST Grp (2017), Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting, New England Journal of Medicine 376(6): 515-525.
- Vuckovic, B.A.; Cannegieter, S.C.; Vlieg, A.V.; Rosendaal, F.R. & Lijfering, W.M. (2017), Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow-up study, Journal of Thrombosis and Haemostasis 15(7): 1430-1435.
- Rozemeijer, K.; Cessie, S. le; Vlieg, A.V.; Rosendaal, F.R.; Vandenbroucke, J.P.; Poole, C. & Cannegieter, S.C. (2017), Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors, American Journal of Epidemiology 185(10): 965-973.
- Gade, I.L.; Braekkan, S.; Naess, I.A.; Hansen, J.B.; Rosendaal, F.; Cannegieter, S.; Overvad, K.; Jensvoll, H.; Hammerstrom, J.; Gran, O.V.; Tjonneland, A.; Kristensen, S.R. & Severinsen, M.T. (2017), Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort, Thrombosis Research 158: 157-160.
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2016), Varying incidences of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the final thread that links them all, European Heart Journal 37: 406-407.
- Braekkan, S.K.; Grosse, S.D.; Okoroh, E.M.; Tsai, J.; Cannegieter, S.C.; Naess, I.A.; Krokstad, S.; Hansen, J.B. & Skjeldestad, F.E. (2016), Venous thromboembolism and subsequent permanent work-related disability, Journal of Thrombosis and Haemostasis 14(10): 1978-1987.
- Eindhoven, D.C.; Staveren, L.N. van; Ikkersheim, D.E.; Cannegieter, S.C.; Erkelens, J.A. van; Schalij, M.J. & Borleffs, C.J.W. (2016), Medical compliance after acute myocardial infarction in STEMI and NSTEMI patients in the Netherlands, European Heart Journal 37: 32-32.
- Lijfering, W.M.; Biedermann, J.S.; Kruip, M.J.H.A.; Leebeek, F.W.G.; Rosendaal, F.R. & Cannegieter, S.C. (2016), Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility, Expert Review of Hematology 9(11): 1023-1030.
- Rein, N. van; Cannegieter, S.C.; Cessie, S. le; Rosendaal, F.R.; Reitsma, P.H.; Meer, F.J.M. van der & Lijfering, W.M. (2016), Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects, American Journal of Epidemiology 183(10): 930-936.
- Biedermann, J.S.; Cannegieter, S.C.; Roest, M.; Meer, F.J.M. van der; Reitsma, P.H.; Kruip, M.J.H.A. & Lijfering, W.M. (2016), Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial, Journal of Thrombosis and Haemostasis 14(7): 1404-1409.
- Silvis, S.M.; Middeldorp, S.; Zuurbier, S.M.; Cannegieter, S.C. & Coutinho, J.M. (2016), Risk Factors for Cerebral Venous Thrombosis, Seminars in Thrombosis and Hemostasis 42(6): 622-631.
- Elbers, L.P.B.; Boon, H.A.; Moes, M.I.; Zaane, B. van; Brandjes, D.P.M.; Fliers, E.; Buller, H.R.; Cannegieter, S. & Gerdes, V.E.A. (2016), Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery, European Thyroid Journal 5(2).
- Zuurbier, S.M.; Arnold, M.; Middeldorp, S.; Broeg-Morvay, A.; Silvis, S.M.; Heldner, M.R.; Meisterernst, J.; Nemeth, B.; Meulendijks, E.R.; Stam, J.; Cannegieter, S.C. & Coutinho, J.M. (2016), Risk of Cerebral Venous Thrombosis in Obese Women, JAMA Neurology 73(5): 579-584.
- Dronkers, C.E.A.; Hulle, T. van der; Ende-Verhaar, Y.M.; Cannegieter, S.C.; Huisman, M.V. & Klok, F.A. (2016), Association of disease prevalence and failure rate in diagnostic management studies in suspected pulmonary embolism: towards a new tailored standard for future studies, European Heart Journal 37: 953-953.
- Raeven, V.M.; Spoorenberg, S.M.C.; Boersma, W.G.; Garde, E.M.W. van de; Cannegieter, S.C.; Voorn, G.P.P.; Bos, W.J.W.; Steenbergen, J.E. van; Alkmaar Study Grp & Ovidius Study Grp (2016), Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts, BMC Infectious Diseases 16.
- Rein, N. van; Cessie, S. le; Vliet, I.P. van; Reitsma, P.H.; Meer, F.J.M. van der; Lijfering, W.M. & Cannegieter, S.C. (2016), Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors, Journal of Thrombosis and Haemostasis 14(5): 948-952.
- Nemeth, B.; Adrichem, R.A. van & Cannegieter, S.C. (2016), The ERIKA trial: still limited evidence on the efficacy of thromboprophylaxis after knee arthroscopy, Thrombosis and Haemostasis 116(5): 1001-1001.
- Kearon, C.; Ageno, W.; Cannegieter, S.C.; Cosmi, B.; Geersing, G.J.; Kyrle, P.A.; Subcomm Control Anticoagulation & Subcomm Predictive Diagnostic (2016), Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH, Journal of Thrombosis and Haemostasis 14(7): 1480-1483.
- Ribeiro, D.D.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2016), Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors, Journal of Thrombosis and Haemostasis 14(8): 1572-1578.
- Scheres, L.J.J.; Lijfering, W.M.; Middeldorp, S. & Cannegieter, S.C. (2016), Influence of World Thrombosis Day on digital information seeking on venous thrombosis: a Google Trends study, Journal of Thrombosis and Haemostasis 14(12): 2325-2328.
- Elbers, L.P.B.; Boon, H.A.; Moes, M.I.; Zaane, B. van; Brandjes, D.P.M.; Fliers, E.; Buller, H.R.; Cannegieter, S. & Gerdes, V.E.A. (2016), Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery, European Thyroid Journal 5(2).
- Rein, N. van; Cessie, S. le; Vliet, I.P. van; Reitsma, P.H.; Meer, F.J.M. van der; Lijfering, W.M. & Cannegieter, S.C. (2016), Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors, Journal of Thrombosis and Haemostasis 14(5): 948-952.
- Rein, N. van; Cannegieter, S.C.; Cessie, S. le; Rosendaal, F.R.; Reitsma, P.H.; Meer, F.J.M. van der & Lijfering, W.M. (2016), Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects, American Journal of Epidemiology 183(10): 930-936.
- Dronkers, C.E.A.; Hulle, T. van der; Ende-Verhaar, Y.M.; Cannegieter, S.C.; Huisman, M.V. & Klok, F.A. (2016), Association of disease prevalence and failure rate in diagnostic management studies in suspected pulmonary embolism: towards a new tailored standard for future studies, European Heart Journal 37: 953-953.
- Raeven, V.M.; Spoorenberg, S.M.C.; Boersma, W.G.; Garde, E.M.W. van de; Cannegieter, S.C.; Voorn, G.P.P.; Bos, W.J.W.; Steenbergen, J.E. van; Alkmaar Study Grp & Ovidius Study Grp (2016), Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts, BMC Infectious Diseases 16.
- Lijfering, W.M.; Biedermann, J.S.; Kruip, M.J.H.A.; Leebeek, F.W.G.; Rosendaal, F.R. & Cannegieter, S.C. (2016), Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility, Expert Review of Hematology 9(11): 1023-1030.
- Kearon, C.; Ageno, W.; Cannegieter, S.C.; Cosmi, B.; Geersing, G.J.; Kyrle, P.A.; Subcomm Control Anticoagulation & Subcomm Predictive Diagnostic (2016), Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH, Journal of Thrombosis and Haemostasis 14(7): 1480-1483.
- Eindhoven, D.C.; Staveren, L.N. van; Ikkersheim, D.E.; Cannegieter, S.C.; Erkelens, J.A. van; Schalij, M.J. & Borleffs, C.J.W. (2016), Medical compliance after acute myocardial infarction in STEMI and NSTEMI patients in the Netherlands, European Heart Journal 37: 32-32.
- Biedermann, J.S.; Cannegieter, S.C.; Roest, M.; Meer, F.J.M. van der; Reitsma, P.H.; Kruip, M.J.H.A. & Lijfering, W.M. (2016), Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial, Journal of Thrombosis and Haemostasis 14(7): 1404-1409.
- Silvis, S.M.; Middeldorp, S.; Zuurbier, S.M.; Cannegieter, S.C. & Coutinho, J.M. (2016), Risk Factors for Cerebral Venous Thrombosis, Seminars in Thrombosis and Hemostasis 42(6): 622-631.
- Zuurbier, S.M.; Arnold, M.; Middeldorp, S.; Broeg-Morvay, A.; Silvis, S.M.; Heldner, M.R.; Meisterernst, J.; Nemeth, B.; Meulendijks, E.R.; Stam, J.; Cannegieter, S.C. & Coutinho, J.M. (2016), Risk of Cerebral Venous Thrombosis in Obese Women, JAMA Neurology 73(5): 579-584.
- Nemeth, B.; Adrichem, R.A. van & Cannegieter, S.C. (2016), The ERIKA trial: still limited evidence on the efficacy of thromboprophylaxis after knee arthroscopy, Thrombosis and Haemostasis 116(5): 1001-1001.
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2016), Varying incidences of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the final thread that links them all, European Heart Journal 37: 406-407.
- Braekkan, S.K.; Grosse, S.D.; Okoroh, E.M.; Tsai, J.; Cannegieter, S.C.; Naess, I.A.; Krokstad, S.; Hansen, J.B. & Skjeldestad, F.E. (2016), Venous thromboembolism and subsequent permanent work-related disability, Journal of Thrombosis and Haemostasis 14(10): 1978-1987.
- J. M. T. A. Meessen, W. F. Peter, R. Wolterbeek, S. C. Cannegieter, C. Tilbury, M. R. Bénard, H. M. J. van der Linden, R. Onstenk, R. Tordoir, S. B. Vehmeijer, S. H. M. Verdegaal, H. M. Vermeulen, R. G. H. H. Nelissen & T. P. M. Vliet Vlieland (2016), Patients who underwent total hip or knee arthroplasty are more physically active than the general Dutch population, Rheumatology International 37(2).
- Morelli, V.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2015), Lipid levels and risk of recurrent venous thrombosis: results from the mega follow-up study, Journal of Thrombosis and Haemostasis 13: 960-961.
- Timp J., le Cessie S., Vlieg van Hylckama A., Rosendaal F. R. & Cannegieter S. C. (2015), Long-haul travel and the risk of recurrent venous thrombosis, Journal of Thrombosis and Haemostasis 13: 725-725.
- Nemeth, B.; Adrichem, R.A. van; Cessie, S. le; Vlieg, A.V.; Baglin, T.; Rosendaal, F.R. & Cannegieter, S.C. (2015), Prediction of venous thrombosis risk after arthroscopy of the knee, Journal of Thrombosis and Haemostasis 13: 978-978.
- Adrichem, R.A. van; Tolen, N.J.; Goldman, L.A.; Boef, A.G.; Rein, N.; Driessen, M.J.; Vischjager, M.; Schipper, I.B.; Nelissen, R.G.; Rosendaal, F.R. & Cannegieter, S.C. (2015), Prevention of venous thrombosis after an anterior cruciate ligament reconstruction: compression stockings alone vs. its combination with low molecular weight heparin, Journal of Thrombosis and Haemostasis 13: 454-455.
- Timp J. F., Cannegieter S. C., Tichelaar V. Y., Braekkan S. K., Rosendaal F. R., le Cessie S. & Lijfering W. M. (2015), Risk of first and recurrent venous thrombosis in individuals treated with antibiotics, Journal of Thrombosis and Haemostasis 13: 983-983.
- Jensvoll H., Severinsen M. T., Hammerstrom J., Braekkan S. K., Kristensen S. R., Cannegieter S. C., Blix K., Tjonneland A., Rosendaal F. R., Dziewiecka O., Overvad K., Naess I. A. & Hansen J-B (2015), Risk of subsequent cancer after a venous thromboembolism - the Scandinavian Thrombosis and Cancer (STAC) Study, Journal of Thrombosis and Haemostasis 13: 546-546.
- Rezende S., Lijfering W., Bos M., Meijers J., Rosendaal F. & Cannegieter S. (2015), Risk of venous thrombosis and coagulation profile in Dutch natives and immigrants in the Netherlands: results from the mega study, Journal of Thrombosis and Haemostasis 13: 451-451.
- Vuckovic B., van Rein N., Cannegieter S., Rosendaal F. & Lijfering W. (2015), Risk of venous thrombosis in individuals using vitamin supplements: a case-control study, Journal of Thrombosis and Haemostasis 13: 143-144.
- Coutinho J. M., Zuurbier S. M., Broeg-Morvay A., Heldner M., Rosendaal F. R., Stam J., Arnold M., Middeldorp S. & Cannegieter S. C. (2015), Severe obesity is a risk factor for cerebral venous thrombosis: a case-control study, Journal of Thrombosis and Haemostasis 13: 697-698.
- Zuurbier S. M., Broeg-Morvay A., Silvis S. M., Rosendaal F. R., Stam J., Arnold M., Middeldorp S., Cannegieter S. C. & Coutinho J. M. (2015), Severe obesity is a risk factor for cerebral venous thrombosis: A case-control study, International Journal of Stroke 10: 53-53.
- Roach, R.; Lijfering, W.; Tait, R.C.; Baglin, T.; Kyrle, P.; Cannegieter, S. & Rosendaal, F. (2015), Sex difference in the risk of venous thrombosis: a detailed analysis in four European cohorts, Journal of Thrombosis and Haemostasis 13: 145-145.
- Lijfering W., Braekkan S., Caram-Deeelder C., Siegerink B., Vlieg van Hylckama A., le Cessie S., Rosendaal F. & Cannegieter S. (2015), Statin use and risk of recurrent venous thrombosis: results from the mega follow-up study, Journal of Thrombosis and Haemostasis 13: 50-50.
- Vuckovic, B.A.; Rein, N. van; Cannegieter, S.C.; Rosendaal, F.R. & Lijfering, W.M. (2015), Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study, American Journal of Clinical Nutrition 101(3): 606-612.
- Nemeth, B.; Timp, J.F.; Rosendaal, F.R. & Cannegieter, S.C. (2015), The risk of recurrent venous thrombosis in patients with (LOWER) leg cast immobilisation, Journal of Thrombosis and Haemostasis 13: 959-959.
- Crobach M., Jensvoll H., Severinsen M., Hammerstrom J., Braekkan S., Blix K., Kristensen S., Tjonneland A., Rosendaal F., Overvad K., Hansen J-B, Naess I & Cannegieter S. (2015), Survival after cancer-associated venous thrombosis: results from the Scandinavian Thrombosis and Cancer (STAC) study, Journal of Thrombosis and Haemostasis 13: 227-227.
- Yap E. S., Timp J. F., Vlieg van Hylckama A., Rosendaal F. R., Cannegieter S. C. & Lijfering W. M. (2015), The increased risk of arterial cardiovascular disease in patients with prior venous thrombosis is not explained through elevated levels of procoagulant factors, Journal of Thrombosis and Haemostasis 13: 218-218.
- Kooiman, J.; Exter, P.L. den; Kilicsoy, I.; Cannegieter, S.C.; Eikenboom, J.; Huisman, M.V.; Klok, F.A. & Versteeg, H.H. (2015), Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism, Journal of Thrombosis and Thrombolysis 40(3): 323-330.
- Nemeth, B.; Adrichem, R.A. van; Vlieg, A.V.; Bucciarelli, P.; Martinelli, I.; Baglin, T.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2015), Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
- Scheres L., Lijfering W., van Hylckama Vlieg A., Middeldorp S. & Cannegieter S. (2015), Switching type of oral contraceptive and risk of venous thromboembolism: a case-crossover study, Journal of Thrombosis and Haemostasis 13: 687-688.
- Yap, E.S.; Timp, J.F.; Flinterman, L.E.; Vlieg, A.V.; Rosendaal, F.R.; Cannegieter, S.C. & Lijfering, W.M. (2015), Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study, Journal of Thrombosis and Haemostasis 13(10): 1833-1842.
- Timp, J.F.; Lijfering, W.M.; Flinterman, L.E.; Vlieg, A.V.; Cessie, S. le; Rosendaal, F.R. & Cannegieter, S.C. (2015), Predictive value of factorVIII levels for recurrent venous thrombosis: results from the MEGA follow-up study, Journal of Thrombosis and Haemostasis 13(10): 1823-1832.
- Roach, R.E.J.; Lijfering, W.M.; Tait, R.C.; Baglin, T.; Kyrle, P.A.; Cannegieter, S.C. & Rosendaal, F.R. (2015), Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts, Journal of Thrombosis and Haemostasis 13(10): 1815-1822.
- Kooiman, J.; Hagen, N. van; Sol, A.I. del; Planken, E.V.; Lip, G.Y.H.; Meer, F.J.M. van der; Cannegieter, S.C.; Klok, F.A. & Huisman, M.V. (2015), The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment, PLoS ONE 10(4).
- Braekkan S., Grosse S., Okoroh E. M., Tsai J., Cannegieter S. C., Naess I. A., Krokstad S., Hansen J-B & Skjeldestad F-E (2015), Unprovoked deep vein thrombosis is associated with future risk of disability pension, Journal of Thrombosis and Haemostasis 13: 145-145.
- Adrichem, R.A. van; Oosten, J.P. van; Cannegieter, S.C.; Schipper, I.B. & Nelissen, R.G.H.H. (2015), Thromboprophylaxis for lower leg cast immobilisation and knee arthroscopy: a survey study, Netherlands Journal of Medicine 73(1): 23-29.
- Spronk Henri M. H., Cannegieter Suzanne, Morange Pierre, Hackeng Tilman, Huisman Menno, Nagler Michael, Posthuma Jelle, Ninivaggi Marisa, Zwaveling Suzanne, van der Hulle Tom, Scheres Luuk J. J., van Mens Thijs E. & Mackman Nigel (2015), Theme 2: Epidemiology, Biomarkers, and Imaging of Venous Thromboembolism (and postthrombotic syndrome), Thrombosis Research 136: S8-S12.
- Heijden, A.C. van der; Borleffs, C.J.W.; Buiten, M.S.; Thijssen, J.; Rees, J.B. van; Cannegieter, S.C.; Schalij, M.J. & Erven, L. van (2015), The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications, Heart Rhythm 12(6): 1169-1176.
- Ribeiro D., Lijfering W. M., Rosendaal F. R. & Cannegieter S. C. (2015), Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors: a case-control study, Journal of Thrombosis and Haemostasis 13: 955-955.
- Cannegieter, S.C.; Horvath-Puho, E.; Schmidt, M.; Dekkers, O.M.; Pedersen, L.; Vandenbroucke, J.P. & Sorensen, H.T. (2015), Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study, Blood 125(2): 229-235.
- Stoof, S.C.M.; Steenbergen, H.W. van; Zwagemaker, A.; Sanders, Y.V.; Cannegieter, S.C.; Duvekot, J.J.; Leebeek, F.W.G.; Peters, M.; Kruip, M.J.H.A. & Eikenboom, J. (2015), Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey, Haemophilia 21(4): 505-512.
- Biedermann J., Cannegieter S., van der Meer F., Kruip M., Reitsma P. & Lijfering W. (2015), Platelet reactivity in patients with a history of venous thrombosis who use rosuvastatin: randomized clinical trial, Journal of Thrombosis and Haemostasis 13: 488-488.
- van Rein N., de Geus K. S., Cannegieter S. C., Reitsma P. H., van der Meer F. J. & Lijfering W. M. (2015), Multi-dose drug dispensing as a tool to improve medication adherence: a crossover study, Journal of Thrombosis and Haemostasis 13: 993-993.
- Coutinho J. M., Zuurbier S. M., Stam J., Middeldorp S. & Cannegieter S. C. (2015), Is anemia a risk factor for cerebral venous thrombosis?, Journal of Thrombosis and Haemostasis 13: 138-139.
- Rein, N. V, Lijfering W. M., van Vliet I. P., van der Meer F. J., le Cessie S., Cannegieter S. C. & Reitsma P. H. (2015), Increased risk for major bleeds after minor bleeds is determined by unknown persistent common risk factors, Journal of Thrombosis and Haemostasis 13: 993-994.
- Van der Bom J. G. & Cannegieter S. C. (2015), Hospital-acquired anemia: the contribution of diagnostic blood loss, Journal of Thrombosis and Haemostasis 13(6): 1157-1159.
- Venemans-Jellema A., Elbers L., Middeldorp S., Gerdes V & Cannegieter S. (2015), Higher frequency of left-sided deep vein thrombosis in postpartum period, Journal of Thrombosis and Haemostasis 13: 107-107.
- Flinterman, L.E.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2015), Body height, mobility, and risk of first and recurrent venous thrombosis, Journal of Thrombosis and Haemostasis 13(4): 548-554.
- Schut, A.M.; Venemans-Jellema, A.; Meijers, J.C.M.; Middeldorp, S.; Groot, P.G. de; Rosendaal, F.R.; Roest, M.; Lisman, T. & Cannegieter, S.C. (2015), Coagulation activation during air travel is not initiated via the extrinsic pathway, British Journal of Haematology 169(6): 903-905.
- Elbers L., van Zaane B., Gerdes V. E., Dekkers O. M., Vlieg van Hylckama A. & Cannegieter S. (2015), Glucocorticoid receptor gene and risk of venous thromboembolism, Journal of Thrombosis and Haemostasis 13: 198-198.
- Rein, N. V, Heide-Jorgensen U., Lijfering W. M., Pedersen L., Dekkers O. M., Sorensen H. T. & Cannegieter S. C. (2015), Bleeding risks are high in elderly persons who use vitamin k antagonists combined with platelet aggregation inhibitors, Journal of Thrombosis and Haemostasis 13: 131-131.
- Coutinho, J.M.; Zuurbier, S.M.; Gaartman, A.E.; Dikstaal, A.A.; Stam, J.; Middeldorp, S. & Cannegieter, S.C. (2015), Association Between Anemia and Cerebral Venous Thrombosis Case-Control Study, Stroke 46(10): 2735-2740.
- Scheres L., Middeldorp S., Rosendaal F. R. & Cannegieter S. C. (2015), Age of menarche and risk of venous thromboembolism, Journal of Thrombosis and Haemostasis 13: 448-448.
- Blix K., Severinsen M. T., Braekkan S., Jensvoll H., Dziewiecka O., Kristensen S. R., Overvad K., Tjonneland A., Naess I. A., Hammerstrom J., Rosendaal F. R., Cannegieter S. C. & Hansen J-B (2015), Age should not be considered a risk factor for cancer-related venous thromboembolism: results from the Scandinavian thrombosis and cancer study, Journal of Thrombosis and Haemostasis 13: 549-549.
- Blix K., Severinsen M. T., Braekkan S., Jensvoll H., Dziewiecka O., Kristensen S. R., Overvad K., Tjonneland A., Naess I. A., Hammerstrom J., Rosendaal F. R., Cannegieter S. C. & Hansen J-B (2015), Cancer-related venous thromboembolism in the general population: results from the Scandinavian Thrombosis and Cancer (STAC) study, Journal of Thrombosis and Haemostasis 13: 549-549.
- Jensvoll H., Severinsen M. T., Hammerstrom J., Braekkan S. K., Kristensen S. R., Cannegieter S. C., Blix K., Tjonneland A., Rosendaal F. R., Dziewiecka O., Overvad K., Naess I. A. & Hansen J-B (2015), Cohort profile: the Scandinavian Thrombosis and Cancer (STAC) Study, Journal of Thrombosis and Haemostasis 13: 143-143.
- Yap E. S., Timp J. F., Flinterman L. E., Vlieg van Hylckama A., Rosendaal F. R., Cannegieter S. C. & Lijfering W. M. (2015), Elevated factor VIII levels and all-cause mortality: results from the mega follow-up study, Journal of Thrombosis and Haemostasis 13: 832-832.
- Rietveld I. M., Bos M. H. A., Rosendaal F. R., Reitsma P. H. & Cannegieter S. C. (2015), Factor V is associated with a moderately increased risk of venous thrombosis, Journal of Thrombosis and Haemostasis 13: 485-485.
- Gade I. L., Braekkan S. K., Naess I. A., Hansen J-B, Rosendaal F. R., Cannegieter S. C., Overvad K., Jensvoll H., Hammerstrom J., Blix K., Tjonneland A., Kristensen S. R. & Severinsen M. T. (2015), Impact of initial cancer stage on the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Study, Journal of Thrombosis and Haemostasis 13: 30-30.
- Morelli, V.M.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2015), Lipid levels and risk of venous thrombosis: results from the MEGA study, Journal of Thrombosis and Haemostasis 13: 152-152.
- Adrichem, R.A. van; Nelissen, R.G.H.H.; Schipper, I.B.; Rosendaal, F.R. & Cannegieter, S.C. (2015), Risk of venous thrombosis after arthroscopy of the knee: results from a large population-based case-control study, Journal of Thrombosis and Haemostasis 13(8): 1441-1448.
- Debeij, J.; Zaane, B. van; Dekkers, O.M.; Doggen, C.J.M.; Smit, J.W.A.; Zanten, A.P. van; Brandjes, D.P.M.; Buller, H.R.; Gerdes, V.E.A.; Rosendaal, F.R. & Cannegieter, S.C. (2014), High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study, Journal of Thrombosis and Haemostasis 12(6): 839-846.
- Kroner, E.S.J.; Lamb, H.J.; Siebelink, H.M.J.; Cannegieter, S.C.; Boogaard, P.J. van den; Wall, E.E. van der; Roos, A. de & Westenberg, J.J.M. (2014), Pulse Wave Velocity and Flow in the Carotid Artery Versus the Aortic Arch: Effects of Aging, Journal of Magnetic Resonance Imaging 40(2): 287-293.
- Bosch, J.; Nooij, J. de; Visser, M. de; Cannegieter, S.C.; Terpstra, N.J.; Heringhaus, C. & Burggraaf, J. (2014), Prehospital use in emergency patients of a laryngeal mask airway by ambulance paramedics is a safe and effective alternative for endotracheal intubation, Emergency Medicine Journal 31(9): 750-753.
- Rodrigo, S.F.; Ramshorst, J. van; Mann, I.; Leong, D.P.; Cannegieter, S.C.; Younis, I. al; Dibbets-Schneider, P.; Roos, A. de; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2014), Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia, International Journal of Cardiology 175(3): 539-544.
- Blix, K.; Braekkan, S.K.; Cessie, S. le; Skjeldestad, F.E.; Cannegieter, S.C. & Hansen, J.B. (2014), The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromso study, European Journal of Epidemiology 29(4): 277-284.
- Schmidt, M.; Cannegieter, S.C.; Johannesdottir, S.A.; Dekkers, O.M.; Horvath-Puho, E. & Sorensen, H.T. (2014), Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study, Journal of Thrombosis and Haemostasis 12(8): 1207-1215.
- Cannegieter, S. (2014), Sex-specific aspects of venous thrombosis, European Journal of Clinical Investigation 44: 5-5.
- Ocak, G.; Vossen, C.Y.; Lijfering, W.M.; Verduijn, M.; Dekker, F.W.; Rosendaal, F.R. & Cannegieter, S.C. (2014), Role of Hemostatic Factors on the Risk of Venous Thrombosis in People With Impaired Kidney Function, Circulation 129(6): 683-691.
- Lind, C.; Flinterman, L.E.; Enga, K.F.; Severinsen, M.T.; Kristensen, S.R.; Braekkan, S.K.; Mathiesen, E.B.; Njolstad, I.; Cannegieter, S.C.; Overvad, K. & Hansen, J.B. (2014), Response to Letter Regarding Article, "Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases", Circulation 130(21): E184-E185.
- Kooiman, J.; Sijpkens, Y.W.J.; Vries, J.P.P.M. de; Brulez, H.F.H.; Hamming, J.F.; Molen, A.J. van der; Aarts, N.J.M.; Cannegieter, S.C.; Putter, H.; Swarts, R.; Hout, W.B. van den; Rabelink, T.J. & Huisman, M.V. (2014), A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography, Nephrology Dialysis Transplantation 29(5): 1029-1036.
- Roach, R.E.J.; Venemans, A.; Cannegieter, S.C. & Lijfering, W.M. (2014), Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment, Journal of Thrombosis and Haemostasis 12(10): 1593-1600.
- Kooiman, J.; Rein, N. van; Spaans, B.; Beers, K.A.J. van; Bank, J.R.; Peppel, W.R.V. de; Sol, A.I. del; Cannegieter, S.C.; Rabelink, T.J.; Lip, G.Y.H.; Klok, F.A. & Huisman, M.V. (2014), Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease, PLoS ONE 9(5).
- Heijden, A.C. van der; Rees, J.B. van; Bom, J.G. van der; Cannegieter, S.C.; Erven, L.; Levy, W.C.; Schalij, M.J. & Borleffs, C.J.W. (2014), FADES, MADIT and SHFM-D risk model validation; Valid tools for risk stratification of ICD recipients in routine clinical practice?, European Heart Journal 35: 765-765.
- Lind, C.; Flinterman, L.E.; Enga, K.F.; Severinsen, M.T.; Kristensen, S.R.; Braekkan, S.K.; Mathiesen, E.B.; Njolstad, I.; Cannegieter, S.C.; Overvad, K. & Hansen, J.B. (2014), Impact of Incident Venous Thromboembolism on Risk of Arterial Thrombotic Diseases, Circulation 129(8): 855-863.
- Kuipers, S.; Venemans, A.; Middeldorp, S.; Buller, H.R.; Cannegieter, S.C. & Rosendaal, F.R. (2014), The risk of venous thrombosis after air travel: contribution of clinical risk factors, British Journal of Haematology 165(3): 412-413.
- Timp, J.F.; Flinterman, L.E.; Vlieg, A.V.; Cessie, S. le; Rosendaal, F.R. & Cannegieter, S.C. (2014), The risk of recurrent venous thrombosis in patients with cancer, Thrombosis Research 133: S192-S192.
- Kuipers, S.; Venemans-Jellema, A.; Cannegieter, S.C.; Haften, M. van; Middeldorp, S.; Buller, H.R. & Rosendaal, F.R. (2014), The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots, Journal of Thrombosis and Haemostasis 12(8): 1260-1265.
- Kooiman, J.; Sijpkens, Y.W.J.; Buren, M. van; Groeneveld, J.H.M.; Ramai, S.R.S.; Molen, A.J. van der; Aarts, N.J.M.; Rooden, C.J. van; Cannegieter, S.C.; Putter, H.; Rabelink, T.J. & Huisman, M.V. (2014), Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography, Journal of Thrombosis and Haemostasis 12(10): 1658-1666.
- Roach, R.E.J.; Lijfering, W.M.; Rosendaal, F.R.; Cannegieter, S.C. & Cessie, S. le (2014), Sex Difference in Risk of Second but Not of First Venous Thrombosis Paradox Explained, Circulation 129(1): 51-+.
- Vlieg, A.V.; Flinterman, L.E.; Bare, L.A.; Cannegieter, S.C.; Reitsma, P.H.; Arellano, A.R.; Tong, C.H.; Devlin, J.J. & Rosendaal, F.R. (2014), Genetic Variations Associated With Recurrent Venous Thrombosis, Circulation: Cardiovascular Genetics 7(6): 806-813.
- Rezende, S.M.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2014), Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk, Haematologica 99(1): 194-200.
- Venemans-Jellema, A.; Schreijer, A.J.M.; Cessie, S. le; Emmerich, J.; Rosendaal, F.R. & Cannegieter, S.C. (2014), No effect of isolated long-term supine immobilization or profound prolonged hypoxia on blood coagulation, Journal of Thrombosis and Haemostasis 12(6): 902-909.
- Adrichem, R.A. van; Debeij, J.; Nelissen, R.G.H.H.; Schipper, I.B.; Rosendaal, F.R. & Cannegieter, S.C. (2014), Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case-control study, Journal of Thrombosis and Haemostasis 12(9): 1461-1469.
- Rein, N. van; Cannegieter, S.C.; Rosendaal, F.R.; Reitsma, P.H. & Lijfering, W.M. (2014), Suspected survivor bias in case-control studies: stratify on survival time and use a negative control, Journal of Clinical Epidemiology 67(2): 232-235.
- Roach, R.E.J.; Lijfering, W.M.; Vlieg, A.V.; Helmerhorst, F.M.; Rosendaal, F.R. & Cannegieter, S.C. (2013), The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors, Blood 122(26): 4264-4269.
- Kooiman, J.; Exter, P.L. den; Cannegieter, S.C.; Cessie, S. le; Toro, J. del; Sahuquillo, J.C.; Pedrajas, J.M. & Huisman, M.V. (2013), Impact of chronic kidney disease and treatment with LMWH on the risk of major bleeding in patients with cancer-associated venous thromboembolism, Journal of Thrombosis and Haemostasis 11: 985-985.
- Roach, R.E.J.; Lijfering, W.M.; Rosendaal, F.R.; Cannegieter, S.C. & Cessie, S. le (2013), Sex difference in incidence of first venous thrombosis: a higher risk in men than in women, Journal of Thrombosis and Haemostasis 11: 152-152.
- Kooiman, J.; Beers, C.A.J. van; Bank, J.R.J.; Spaans, B.; Cannegieter, S.C.; Lip, G.Y.H.; Meer, F.J.M. van der; Rabelink, T.J. & Huisman, M.V. (2013), Predictive value of the HAS-BLED score in patients with atrial fibrillation and chronic kidney disease using vitamin K-antagonists, Journal of Thrombosis and Haemostasis 11: 807-808.
- Adrichem, R.A. van; Debeij, J.; Nelissen, G.H.H.; Schipper, I.B.; Rosendaal, F.R. & Cannegieter, S.C. (2013), Lower leg cast immobilisation and risk of venous thrombosis: results from the MEGA study, Journal of Thrombosis and Haemostasis 11: 68-68.
- Skjeldestad, F.E.; Grosse, S.D.; Okoroh, E.; Braekkan, S.K.; Cannegieter, S.C.; Naess, I.A.; Krokstad, S. & Hansen, J.B. (2013), Venous thromboembolism and subsequent receipt of disability pension - a population-based prospective cohort study, Journal of Thrombosis and Haemostasis 11: 442-443.
- Rezende, S.M.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2013), The risk of venous thrombosis varies in different ethnic groups, Journal of Thrombosis and Haemostasis 11: 150-151.
- Timp, J.; Timp, J.F.; Lijfering, W.M.; Rosendaal, F.R.; Versteeg, H.H. & Cannegieter, S.C. (2013), The risk of venous thrombosis in patients with malignancy is largely mediated through levels of factor VIII and von Willebrand factor, Journal of Thrombosis and Haemostasis 11: 93-94.
- Casais, P.; Engbers, M.J.; Cushman, M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2013), The risk of venous thrombosis after a symptomatic arterial event in an older population, Journal of Thrombosis and Haemostasis 11: 1008-1008.
- Langevelde, K. van; Segers, A.E.; Buller, H.R. & Cannegieter, S.C. (2013), The number of venous valves in the legs does not explain the association between body height and risk of venous thrombosis, Journal of Thrombosis and Haemostasis 11: 614-614.
- Schmidt, M.; Cannegieter, S.C.; Johannesdottir, S.A.; Dekkers, O.M.; Horvath-Puho, E. & Sorensen, H.T. (2013), Statin Use and Venous Thromboembolism Recurrence: A Combined Nationwide Cohort and Nested Case-control Study, Circulation 128(22).
- Rein, N. van; Willem, L.M.; Cannegieter, S.C.; Rosendaal, F.R.; Reitsma, P.H. & Meer, J.M. van der (2013), Statin use and bleeding complications during treatment with vitamin K antagonists: a cohort study in 8188 patients with atrial fibrillation, Journal of Thrombosis and Haemostasis 11: 181-182.
- Rietveld, I.M.; Lijfering, W.M.; Bos, M.H.A.; Rosendaal, F.R.; Reitsma, P.H. & Cannegieter, S.C. (2013), Risk of venous thrombosis associated with coagulation factor VIII levels and the interrelation of other procoagulant and environmental risk factors, Journal of Thrombosis and Haemostasis 11: 843-843.
- Rezende, S.M.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2013), Red cell distribution width and blood monocytes are associated with an increased risk of venous thrombosis, Journal of Thrombosis and Haemostasis 11: 227-227.
- Timp, J.; Stegeman, B.H.; Timp, J.F.; Flinterman, L.E.; Helmerhorst, F.M.; Rosendaal, F.R.; Cannegieter, S.C. & Vlieg, A.V. (2013), Recurrent venous thrombosis in premenopausal women: effect of hormonal contraceptive use, Journal of Thrombosis and Haemostasis 11: 115-116.
- Kooiman, J.; Hagen, N. van; Sol, A.I. del; Planken, E.; Lip, G.Y.H.; Meer, F.J.M. van der; Cannegieter, S.C. & Huisman, M.V. (2013), Predictive value of the HAS-BLED score for major bleeding in patients with venous thromboembolism during anticoagulant treatment, Journal of Thrombosis and Haemostasis 11: 441-441.
- Nemeth, B.; Adrichem, R.A. van; Cessie, S. le; Vlieg, A.V.; Bucciarelli, P.; Martinelli, I.; Baglin, T.P.T.; Rosendaal, F.R. & Cannegieter, S.C. (2013), Prediction of risk of venous thrombosis after cast immobilization of the lower extremity, Journal of Thrombosis and Haemostasis 11: 438-439.
- Vlieg, A.V.; Flinterman, L.E.; Bare, L.A.L.; Cannegieter, S.C.; Arellano, A.R.; Tong, C.H.; Devlin, J. & Rosendaal, F.R. (2013), Assessment of the risk of recurrent venous thrombosis using a genetic risk score comprising five genetic markers, Journal of Thrombosis and Haemostasis 11: 27-28.
- Adrichem, R.A. van; Nelissen, G.H.H.; Schipper, I.B.; Rosendaal, F.R. & Cannegieter, S.C. (2013), Arthroscopy of the knee and risk of venous thrombosis: results from the MEGA study, Journal of Thrombosis and Haemostasis 11: 215-215.
- Stoof, C.M.; Steenbergen, H.W. van; Sanders, Y.V.; Cannegieter, S.C.; Duvekot, J.; Leebeek, F.W.G.; Kruip, J.H.A. & Eikenboom, H.C.J. (2013), High rate of postpartum hemorrhage in women with von Willebrand disease or carriership of hemophilia, despite specialized care, Journal of Thrombosis and Haemostasis 11: 48-48.
- Braekkan, S.K.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2013), High sensitivity C-reactive protein, body mass index, factor VIII levels and risk of venous thrombosis: results from the MEGA study, Journal of Thrombosis and Haemostasis 11: 15-15.
- Kooiman, J.; Sijpkens, Y.W.; Buren, M. van; Groeneveld, M.J.; Ramai, S.; Molen, A.I. van der; Aarts, N.J.; Rooden, C.J. van; Cannegieter, S.C.; Putter, H.; Rabelink, T.J. & Huisman, M.V. (2013), Hydration Prior to CT-Pulmonary Angiography is Not Required for Prevention of Contrast Induced-Acute Kidney Injury: The Randomized Nefros Trial, Circulation 128(22).
- Lind, C.; Flinterman, L.E.; Enga, K.F.; Severinsen, M.T.; Kristensen, S.R.; Braekkan, S.K.; Cannegieter, S.C.; Overvad, K. & Hansen, J.B. (2013), Impact of incident venous thromboembolism on future risk of arterial thrombotic disease, Journal of Thrombosis and Haemostasis 11: 101-101.
- Kooiman, J.; Spaans, B.; Peppel, R. van de; Beers, C.A.J. van; Cannegieter, S.C.; Meer, F.J.M. van der; Rabelink, T.J. & Huisman, M.V. (2013), Increased arterial thrombo-embolic events and major bleeding in patients with atrial fibrillation and chronic kidney disease on vitamin K-antagonist treatment, Journal of Thrombosis and Haemostasis 11: 600-600.
- Kooiman, J.; Rein, N. van; Hagen, N. van; Cannegieter, S.C.; Meer, F.M. van der & Huisman, M.V. (2013), Increased Risk of Major Bleeding Complications in Women During Vka Treatment for Acute Venous Thromboembolism, Circulation 128(22).
- Flinterman, L.E.; Lind, C.; Severinsen, M.T.; Cannegieter, S.C.; Hansen, J.B. & Overvad, K. (2013), Increased risk of venous thrombosis after arterial thrombosis: causal or explained by common risk factors?, Journal of Thrombosis and Haemostasis 11: 214-215.
- Cannegieter, S.C. & Vlieg, A.V. (2013), Venous thrombosis: understanding the paradoxes of recurrence, Journal of Thrombosis and Haemostasis 11: 161-169.
- Johannesdottir, S.A.; Horvath-Puho, E.; Dekkers, O.M.; Cannegieter, S.C.; Jorgensen, J.O.L.; Ehrenstein, V.; Vandenbroucke, J.P.; Pedersen, L. & Sorensen, H.T. (2013), Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study, JAMA Internal Medicine 173(9): 743-752.
- Kooiman, J.; Haen, P.A. le; Gezgin, G.; Vries, J.P.P.M. de; Boersma, D.; Brulez, H.F.H.; Sijpkens, Y.W.J.; Molen, A.J. van der; Cannegieter, S.C.; Hamming, J.F. & Huisman, M.V. (2013), Untitle Reply, American Heart Journal 166(5): 798-798.
- Rhee, J.I. van der; Boonk, S.E.; Putter, H.; Cannegieter, S.C.; Flinterman, L.E.; Hes, F.J.; Snoo, F.A. de; Mooi, W.J.; Gruis, N.A.; Vasen, H.F.A.; Kukutsch, N.A. & Bergman, W. (2013), Surveillance of Second-Degree Relatives from Melanoma Families with a CDKN2A Germline Mutation, Cancer Epidemiology, Biomarkers and Prevention 22(10): 1771-1777.
- Heijden, A.A.W.A. van der; van't Riet, E.; Bot, S.D.M.; Cannegieter, S.C.; Stehouwer, C.D.A.; Baan, C.A.; Dekker, J.M. & Nijpels, G. (2013), Risk of a Recurrent Cardiovascular Event in Individuals With Type 2 Diabetes or Intermediate Hyperglycemia The Hoorn Study, Diabetes Care 36(11): 3498-3502.
- Boden, H.; Velders, M.A.; Hoeven, B.L. van der; Cannegieter, S.C. & Schalij, M.J. (2013), Risk and prognosis of in-hospital major bleeding after primary percutaneous coronary intervention for ST-elevation myocardial infarction, European Heart Journal 34: 400-401.
- Velders, M.A.; Boden, H.; Hofma, S.H.; Osanto, S.; Hoeven, B.L. van der; Heestermans, A.A.C.M.; Cannegieter, S.C.; Jukema, J.W.; Umans, V.A.W.M.; Schalij, M.J. & , A.J. van boven (2013), Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention, American Journal of Cardiology 112(12): 1867-1872.
- Dekkers, O.M.; Horvath-Puho, E.; Jorgensen, J.O.L.; Cannegieter, S.C.; Ehrenstein, V.; Vandenbroucke, J.P.; Pereira, A.M. & Sorensen, H.T. (2013), Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study, Journal of Clinical Endocrinology and Metabolism 98(6): 2277-2284.
- Rodrigo, S.F.; Ramshorst, J. van; Hoogslag, G.E.; Boden, H.; Velders, M.A.; Cannegieter, S.C.; Roelofs, H.; Younis, I. al; Dibbets-Schneider, P.; Fibbe, W.E.; Zwaginga, J.J.; Bax, J.J.; Schalij, M.J.; Beeres, S.L. & Atsma, D.E. (2013), Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up, Journal of Cardiovascular Translational Research 6(5): 816-825.
- Boden, H.; Velders, M.A.; Hoeven, B.L. van der; Cannegieter, S.C. & Scholij, M.J. (2013), In-Hospital Major Bleeding and Its Clinical Relevance in Patients With ST Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention, American Journal of Cardiology 112(10): 1533-1539.
- Velders, M.A.; Boden, H.; , A.J. van boven; Hoeven, B.L. van der; Heestermans, A.A.C.M.; Cannegieter, S.C.; Umans, V.A.W.M.; Jukema, J.W.; Hofma, S.H. & Schalij, M.J. (2013), Influence of Gender on Ischemic Times and Outcomes After ST-Elevation Myocardial Infarction, American Journal of Cardiology 111(3): 312-318.
- Kooiman, J.; Exter, P.L. den; Cannegieter, S.C.; Cessie, S. le; Toro, J. del; Sahuquillo, J.C.; Pedrajas, J.M. & Huisman, M.V. (2013), Impact of chronic kidney disease on the risk of clinical outcomes in patients with cancer-associated venous thromboembolism during anticoagulant treatment, Journal of Thrombosis and Haemostasis 11(11): 1968-1976.
- Gademan, M.G.J.; Exel, H.J. van; Vooren, H. van de; Haest, J.C.W.; Pelt, J. van; Laarse, A. van der; Cannegieter, S.C.; Lucas, C.M.H.B.; Somer, S.; Verwey, H.F.; Schalij, M.J.; Wall, E.E. van der & Swenne, C.A. (2013), Exercise-resembling effects of periodic somatosensory stimulation in heart failure, International Journal of Cardiology 168(4): 3327-3333.
- Timp, J.F.; Braekkan, S.K.; Versteeg, H.H. & Cannegieter, S.C. (2013), Epidemiology of cancer-associated venous thrombosis, Blood 122(10): 1712-1723.
- Kooiman, J.; Haen, P.A. le; Gezgin, G.; Vries, J.P.P. de; Boersma, D.; Brulez, H.F.; Sijpkens, Y.W.; Molen, A.J. van der; Cannegieter, S.C.; Hamming, J.F. & Huisman, M.V. (2013), Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: Risk comparison adjusted for patient characteristics by design, American Heart Journal 165(5): 793-+.
- Ocak, G.; Vossen, C.Y.; Verduijn, M.; Dekker, F.W.; Rosendaal, F.R.; Cannegieter, S.C. & Lijfering, W.M. (2013), Risk of venous thrombosis in patients with major illnesses: results from the MEGA study, Journal of Thrombosis and Haemostasis 11(1): 116-123.
- Braekkan, S.K.; Siegerink, B.; Lijfering, W.M.; Hansen, J.B.; Cannegieter, S.C. & Rosendaal, F.R. (2013), Role of Obesity in the Etiology of Deep Vein Thrombosis and Pulmonary Embolism: Current Epidemiological Insights, Seminars in Thrombosis and Hemostasis 39(5): 533-540.
- Roach, R.E.J.; Lijfering, W.M.; Helmerhorst, F.M.; Cannegieter, S.C.; Rosendaal, F.R. & Vlieg, A.V. (2013), The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
- Ocak, G.; Lijfering, W.M.; Verduijn, M.; Dekker, F.W.; Rosendaal, F.R.; Cannegieter, S.C. & Vossen, C.Y. (2013), Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups, Journal of Thrombosis and Haemostasis 11(4): 627-633.
- Cannegieter, S.C. & Rosendaal, F.R. (2013), Pregnancy and travel-related thromboembolism, Thrombosis Research 131: S55-S58.
- Timp, J.F.; Lijfering, W.M.; Flinterman, L.E.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2013), Predictive value of high factor VIII levels for recurrent venous thrombosis, Journal of Thrombosis and Haemostasis 11: 50-51.
- Roach, R.E.; Siegerink, B.; Cessie, S. le; Rosendaal, F.R.; Cannegieter, S.C. & Lijfering, W.M. (2013), Coffee consumption and a reduced risk of venous thrombosis: mediated through hemostatic factors, Journal of Thrombosis and Haemostasis 11: 81-81.
- Huidekoper, A.L.; Woude, D. van der; Knevel, R.; Helm-van Mil, A.H.M. van der; Cannegieter, S.C.; Rosendaal, F.R.; Kloppenburg, M. & Huizinga, T.W.J. (2013), Patients with early arthritis consume less alcohol than controls, regardless of the type of arthritis, Rheumatology 52(9): 1701-1707.
- Roach, R.E.J.; Lijfering, W.M.; Flinterman, L.E.; Rosendaal, F.R. & Cannegieter, S.C. (2013), Increased risk of CVD after VT is determined by common etiologic factors, Blood 121(24): 4948-4954.
- Roach, R.E.J.; Lijfering, W.M.; Vlieg, A.V.; Helmerhorst, F.M.; Rosendaal, F.R. & Cannegieter, S.C. (2013), The risk of venous thrombosis in oral contraception users with a history of superficial thrombophlebitis, Journal of Thrombosis and Haemostasis 11: 7-7.
- Langevelde, K. van; Flinterman, L.E.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2012), Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum, Blood 120(5): 933-946.
- Stuijver, D.J.F.; Debeij, J.; Zaane, B. van; Dekkers, O.M.; Smit, J.W.A.; Buller, H.R.; Rosendaal, F.R.; Gerdes, V.E.A. & Cannegieter, S.C. (2012), Levels of prolactin in relation to coagulation factors and risk of venous thrombosis Results of a large population-based case-control study (MEGA-study), Thrombosis and Haemostasis 108(3): 499-507.
- Debeij, J.; Dekkers, O.M.; Asvold, B.O.; Christiansen, S.C.; Naess, I.A.; Hammerstrom, J.; Rosendaal, F.R. & Cannegieter, S.C. (2012), Increased levels of free thyroxine and risk of venous thrombosis in a large population-based prospective study.
- Mahmoodi, B.K.; Gansevoort, R.T.; Naess, I.A.; Lutsey, P.L.; Braekkan, S.K.; Veeger, N.J.G.M.; Brodin, E.E.; Meijer, K.; Sang, Y.Y.; Matsushita, K.; Hallan, S.I.; Hammerstrom, J.; Cannegieter, S.C.; Astor, B.C.; Coresh, J.; Folsom, A.R.; Hansen, J.B. & Cushman, M. (2012), Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism Pooled Analysis of Five Prospective General Population Cohorts, Circulation 126(16): 1964-+.
- Cannegieter, S.C. (2012), Travel-related thrombosis.
- Roach, R.E.J.; Siegerink, B.; Cessie, S. le; Rosendaal, F.R.; Cannegieter, S.C. & Lijfering, W.M. (2012), Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels.
- Kootte, R.S.; Stuijver, D.J.F.; Dekkers, O.M.; Zaane, B. van; Fliers, E.; Cannegieter, S.C. & Gerdes, V.E.A. (2012), The incidence of venous thromboembolism in patients with overt hyperthyroidism A retrospective multicentre cohort study, Thrombosis and Haemostasis 107(3): 417-422.
- Ahmed, T.A.N.; Sorgdrager, B.J.; Cannegieter, S.C.; Laarse, A. van der; Schalij, M.J. & Jukema, J.W. (2012), Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction.
- Boden, H.; Hoeven, B.L. van der; Liem, S.S.; Atary, J.Z.; Cannegieter, S.C.; Atsma, D.E.; Bootsma, M.; Jukema, J.W.; Zeppenfeld, K.; Oemrawsingh, P.V.; Wall, E.E. van der & Schalij, M.J. (2012), Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial.
- Bie, M.K. de; Rees, J.B. van; Thijssen, J.; Borleffs, C.J.W.; Trines, S.A.; Cannegieter, S.C.; Schalij, M.J. & Erven, L. van (2012), Cardiac device infections are associated with a significant mortality risk, Heart Rhythm 9(4): 494-498.
- Ribeiro, D.D.; Lijfering, W.M.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2012), Pneumonia and risk of venous thrombosis: results from the MEGA study.
- Lisman, T.; Meltzer, M.E.; Cannegieter, S.C. & Rosendaal, F.R. (2012), Plasma levels of Midkine (neurite growth-promoting factor 2) are not associated with plasma fibrinolytic potential or risk of venous thrombosis.
- Flinterman, L.E.; Vlieg, A.V.; Cannegieter, S.C. & Rosendaal, F.R. (2012), Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors, PLoS Medicine 9(1): -.
- Boden, H.; Ahmed, T.; Hoogslag, G.; Bootsma, M.; Cannegieter, S.; Cobbaert, C.; Laarse, A. van der & Schalij, M. (2012), THE VALUE OF SERUM TROPONIN-T TO PREDICT INFARCT SIZE IN PATIENTS WITH FIRST ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN THE ERA OF HIGH SENSITIVE TROPONIN ASSAYS, Journal of the American College of Cardiology 59(13): E403-E403.
- Rees, J.B. van; Borleffs, C.J.W.; Thijssen, J.; Bie, M.K. de; Erven, L. van; Cannegieter, S.C.; Bax, J.J. & Schalij, M.J. (2012), Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain, EP-Europace 14(1): 66-73.
- Christiansen, S.C.; Lijfering, W.M.; Naess, I.A.; Hammerstrom, J.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2012), The relationship between body mass index, activated protein C resistance and risk of venous thrombosis.
- Cessie, S. le; Debeij, J.; Rosendaal, F.R.; Cannegieter, S.C. & Vandenbroucke, J.P. (2012), Quantification of Bias in Direct Effects Estimates Due to Different Types of Measurement Error in the Mediator, EPIDEMIOLOGY 23(4): 551-560.
- Rezende, S.M.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2012), The Risk of Venous Thrombosis in Different Immigrant Groups in the Netherlands, Blood 120(21).
- Rezende, S.M.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2012), The Risk of Venous Thrombosis in Different Immigrant Groups in the Netherlands, Blood 120(21).
- Lijfering, W.M.; Braekkan, S.; Hald, E.M.; Mathiesen, E.B.; Cannegieter, S.C.; Rosendaal, F.R. & Hansen, J.B. (2012), The Association Between Atherosclerosis and Venous Thrombosis: Results From the Tromso Study, Blood 120(21).
- Ribeiro, D.D.; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2011), The Risk for Venous Thrombosis in Patients with Increased Body Mass Index and Interactions with Other Genetic and Acquired Risk Factors: The MEGA Study, Blood 118(21): 554-554.
- Langevelde, K. van; Sramek, A.; Vincken, P.W.J.; Rooden, J.K. van; Rosendaal, F.R. & Cannegieter, S.C. (2011), Is Deep-Vein Thrombosis Always the Origin of Pulmonary Embolism? Imaging of Veins with a Total-Body Direct Thrombus MRI Technique, Blood 118(21): 996-996.
- Flinterman, L.E.; Hylckama, V.A.; Cannegieter, S.C. & Rosendaal, F.R. (2011), Chronic obstructive pulmonary disease and the risk of PE and DVT.
- Langevelde, K. van; Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2011), Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study, Blood 118(15): 4239-4241.
- Timp, J.F.; Flinterman, L.E.; Vlieg, A.V.; Rosendaal, F.R. & Cannegieter, S.C. (2011), Malignancies and risk of recurrent venous thrombosis.
- Flinterman, L.E.; Vlieg, A.H.; Cannegieter, S.C. & Rosendaal, F.R. (2011), Recurrent venous thrombosis: incidence and characteristics in a large cohort of VT patients (MEGA STUDY).
- Cessie, S. le; Debeij, J.; Rosendaal, F.; Cannegieter, S. & Vandenbroucke, J. (2011), SENSITIVITY ANALYSIS FOR AN APPARENT DIRECT EFFECT AFTER CONDITIONING ON AN INTERMEDIATE VARIABLE, Journal of Epidemiology and Community Health 65: A31-A31.
- Vlieg, A.V.; Flinterman, L.E.; Cannegieter, S.C. & Rosendaal, F.R. (2011), The risk of recurrent venous thrombosis associated with oral contraceptive use.
- Bie, M.K. de; Rees, J.B. van; Thijssen, J.; Borleffs, C.J.W.; Trines, S.A.; Cannegieter, S.C.; Schalij, M.J. & Erven, L. van (2011), Cardiac device infections are associated with a significant mortality risk., Heart Rhythm.
- Zaane, B. van; Squizzato, A.; Debeij, J.; Dekkers, O.M.; Meijers, J.C.M.; Zanten, A.P. van; Buller, H.R.; Gerdes, V.E.A.; Cannegieter, S.C. & Brandjes, D.P.M. (2011), Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study.
- Thijssen, J.; Borleffs, C.J.W.; Rees, J.B. van; Bie, M.K. de; Velde, E.T. van der; Erven, L. van; Bax, J.J.; Cannegieter, S.C. & Schalij, M.J. (2011), Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach, European Heart Journal 32(21): 2678-2687.
- Piers, S.R.D.; Wijnmaalen, A.P.; Borleffs, C.J.W.; Taxis, C.F.B.V. van; Thijssen, J.; Rees, J.B. van; Cannegieter, S.C.; Bax, J.J.; Schalij, M.J. & Zeppenfeld, K. (2011), Early Reperfusion Therapy Affects Inducibility, Cycle Length, and Occurrence of Ventricular Tachycardia Late After Myocardial Infarction, Circulation: Arrhythmia and Electrophysiology 4(2): 195-201.
- Stuijver, D.J.; Zaane, B. van; Feelders, R.A.; Debeij, J.; Cannegieter, S.C.; Hermus, A.R.; Berg, G. van den; Pereira, A.M.; Herder, D.W.; Wagenmakers, M.A.; Kerstens, M.N.; Zelissen, P.M.; Fliers, E.; Schaper, N.; Drent, M.L.; Dekkers, O.M. & Gerdes, V.E. (2011), Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study.
- Stuijver, D.J.F.; Zaane, B. van; Feelders, R.A.; Debeij, J.; Cannegieter, S.C.; Hermus, A.R.; Berg, G. van den; Pereira, A.M.; Herder, W.W. de; Wagenmakers, M.A.E.M.; Kerstens, M.N.; Zelissen, P.M.J.; Fliers, E.; Schaper, N.; Drent, M.L.; Dekkers, O.M. & Gerdes, V.E.A. (2011), Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study, Journal of Clinical Endocrinology and Metabolism 96(11): 3525-3532.
- Man, S.; Algra, A.M.; Schreurs, C.A.; Borleffs, C.J.W.; Scherptong, R.W.C.; Erven, L. van; Wall, E.E. van der; Cannegieter, S.C.; Schalij, M.J. & Swenne, C.A. (2011), Influence of the vectorcardiogram synthesis matrix on the power of the electrocardiogram-derived spatial QRS-T angle to predict arrhythmias in patients with ischemic heart disease and systolic left ventricular dysfunction, Journal of Electrocardiology 44(4): 410-415.
- Welsenes, G.H. van; Rees, J.B. van; Borleffs, C.J.W.; Cannegieter, S.C.; Bax, J.J.; Erven, L. van & Schalij, M.J. (2011), Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients, EP-Europace 13(3): 389-394.
- Zaane, B. van; Squizzato, A.; Reuwer, A.Q.; Zanten, A.P. van; Twickler, M.T.B.; Dekkers, O.M.; Cannegieter, S.C.; Buller, H.R.; Gerdes, V.E.A. & Brandjes, D.P.M. (2011), Prolactin and Venous Thrombosis Indications for a Novel Risk Factor?, Arteriosclerosis, Thrombosis, and Vascular Biology 31(3): 672-677.
- Rees, J.B. van; Borleffs, C.J.W.; Thijssen, J.; Erven, L. van; Cannegieter, S.C.; Bax, J.J. & Schalij, M.J. (2011), PROLONGATION OF LIFE WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR TREATMENT IN THE ELDERLY, Journal of the American College of Cardiology 57(14): E141-E141.
- Lijfering, W.M.; Flinterman, L.E.; Vandenbroucke, J.P.; Rosendaal, F.R. & Cannegieter, S.C. (2011), Relationship between Venous and Arterial Thrombosis: A Review of the Literature from a Causal Perspective, Seminars in Thrombosis and Hemostasis 37(8): 884-895.
- Goorhuis, A.; Debast, S.B.; Dutilh, J.C.; Kinschot, C.M. van; Harmanus, C.; Cannegieter, S.C.; Hagen, E.C. & Kuijper, E.J. (2011), Type-Specific Risk Factors and Outcome in an Outbreak With 2 Different Clostridium difficile Types Simultaneously in 1 Hospital.
- Lijfering, W.M.; Rosendaal, F. & Cannegieter, S. (2011), Physical activity and risk of first venous thrombosis: a subgroup analysis within the mega case-control study.
- Petersen, K.; Cannegieter, S.C.; Reijden, T.J. van der; Strijen, B. van; You, D.M.; Babel, B.S.; Philip, A.I. & Dijkshoorn, L. (2011), Diversity and Clinical Impact of Acinetobacter baumannii Colonization and Infection at a Military Medical Center, Journal of Clinical Microbiology 49(1): 159-166.
- Quist-Paulsen, P.; Naess, I.A.; Cannegieter, S.C.; Romundstad, P.R.; Christiansen, S.C.; Rosendaal, F.R. & Hammerstrom, J. (2010), Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2), Haematologica 95(1): 119-125.
- Schreijer, A.J.M.; Reitsma, P.H. & Cannegieter, S.C. (2010), High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?, Haematologica 95(2): 182-184.
- Meltzer, M.E.; Bol, L.; Rosendaal, F.R.; Lisman, T. & Cannegieter, S.C. (2010), Hypofibrinolysis as a risk factor for recurrent venous thrombosis; results of the LETS follow-up study, Journal of Thrombosis and Haemostasis 8(3): 605-607.
- Thijssen, J.; Borleffs, C.J.W.; Bie, M.K. de; Rees, J.B. van; Welsenes, G.H. van; Wall, E.E. van der; Erven, L. van; Bax, J.J.; Cannegieter, S.C. & Schalij, M.J. (2010), THE EFFECT OF ICD REPLACEMENT ON THE REQUIREMENT FOR SURGICAL RE-INTERVENTION DUE TO INFECTIOUS AND NON-INFECTIOUS CAUSES., Journal of the American College of Cardiology 55(10).
- Schreurs, C.A.; Algra, A.M.; Man, S.C.; Cannegieter, S.C.; Wall, E.E. van der; Schalij, M.J.; Kors, J.A. & Swenne, C.A. (2010), The spatial QRS-T angle in the Frank vectorcardiogram: accuracy of estimates derived from the 12-lead electrocardiogram, Journal of Electrocardiology 43(4): 294-301.
- Borleffs, C.J.W.; Thijssen, J.; Bie, M.K. de; Rees, J.B. van; Welsenes, G.H. van; Erven, L. van; Bax, J.J.; Cannegieter, S.C. & Schalij, M.J. (2010), Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications, Pacing and Clinical Electrophysiology 33(8): 1013-1019.
- Zaane, B. van; Squizzato, A.; Huijgen, R.; Zanten, A.P. van; Fliers, E.; Cannegieter, S.C.; Buller, H.R.; Gerdes, V.E.A. & Brandjes, D.P.M. (2010), Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study, Blood 115(22): 4344-4349.
- Man, S.; Algra, A.M.; Schreurs, C.A.; Cannegieter, S.C.; Wall, E.E. van der; Schalij, M.J.; Kors, J.A. & Swenne, C.A. (2010), Accuracy of spatial QRS-T angles: differences between measurements done in standard 12-lead ECGs and in Frank VCGs, European Heart Journal 31: 286-286.
- Vosmaer, A.; Pereira, R.R.; Koenderman, J.S.; Rosendaal, F.R. & Cannegieter, S.C. (2010), Coagulation Abnormalities in Legg-Calve-Perthes Disease, Journal of Bone and Joint Surgery, American Volume 92A(1): 121-128.
- Christiansen, S.C.; Lijfering, W.M.; Helmerhorst, F.M.; Rosendaal, F.R. & Cannegieter, S.C. (2010), Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event, Journal of Thrombosis and Haemostasis 8(10): 2159-2168.
- Lijfering, W.M.; Rosendaal, F.R. & Cannegieter, S.C. (2010), Risk factors for venous thrombosis - current understanding from an epidemiological point of view, British Journal of Haematology 149(6): 824-833.
- Schreijer, A.J.M.; Hoylaerts, M.F.; Meijers, J.C.M.; Lijnen, H.R.; Middeldorp, S.; Buller, H.R.; Reitsma, P.H.; Rosendaal, F.R. & Cannegieter, S.C. (2010), Explanations for coagulation activation after air travel, Journal of Thrombosis and Haemostasis 8(5): 971-978.
- Debeij, J.; Cannegieter, S.C.; Zaane, B. van; Smit, J.W.A.; Corssmit, E.P.M.; Rosendaal, F.R.; Romijn, J.A. & Dekkers, O.M. (2010), The effect of changes in thyroxine and thyroid-stimulating hormone levels on the coagulation system, Journal of Thrombosis and Haemostasis 8(12): 2823-2826.
- Liem SS, Oemrawsingh PV, Cannegieter SC, Le Cessie S, Schreur J, Rosendaal FR & Schalij MJ (2009), Cardiovascular risk in young apparently healthy descendents from Asian Indian migrants in the Netherlands: the SHIVA study, Netherlands Heart Journal 17(4): 155-161.
- Torn M, Cannegieter SC, Bollen WLEM, van der Meer FM, van der Wall EE & Rosendaal FR (2009), Optimal Level of Oral Anticoagulant Therapy for the Prevention of Arterial Thrombosis in Patients With Mechanical Heart Valve Prostheses, Atrial Fibrillation, or Myocardial Infarction A Prospective Study of 4202 Patients, Archives of Internal Medicine -New Series- 169(13): 1203-1209.
- Vandenbroucke JP, Cannegieter SC & Rosendaal FR (2009), Travel and Venous Thrombosis: An Exercise in Thinking About Bias, Annals of Internal Medicine 151(3): 212W47.
- Lijfering WM, Christiansen SC, Rosendaal FR & Cannegieter SC (2009), Contribution of high factor VIII, IX and XI to the risk of recurrent venous thrombosis in factor V Leiden carriers, Journal of Thrombosis and Haemostasis 7(11): 1944-1946.
- Schreijer AJM, Cannegieter SC, Doggen CJM & Rosendaal FR (2009), The effect of flight-related behaviour on the risk of venous thrombosis after air travel, British Journal of Haematology 144(3): 425-429.
- Kuipers S, Cannegieter SC, Doggen CJM & Rosendaal FR (2009), Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers, Blood 113(9): 2064-2069.
- Lufering WM, Christiansen SC, Naess IA, Hammerstrom J, Vlieg AV, Rosendaal F & Cannegieter SC (2009), The Risk of Venous Thrombosis Related to increase in Body Mass Index Is Mediated by Factor VIII Induced APC-Resistance., Blood 114(22): 188-189.
- Lijfering WM, Bezemer ID, Christiansen SC, Naess IA, Rosendaal F, Hammerstrom J & Cannegieter SC (2009), A Replication Study of Gene Variants Associated with Venous Thrombosis. Results From a Population-Based Nested Case-Cohort Study, Blood 114(22): 1531-1531.
- Naess IA, Christiansen SC, Romundstad PR, Cannegieter SC, Blom HJ, Rosendaal FR & Hammerstrom J (2008), Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population - results from the HUNT 2 study, British Journal of Haematology 141(4).
- Levi M, Hovingh GK, Cannegieter SC, Vermeulen M, Buller HR & Rosendaal FR (2008), Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based, Blood 111(9).
- Van Leeuwen Y, Rosendaal FR & Cannegieter SC (2008), Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants, Journal of Thrombosis and Haemostasis 6(3).
- Schreijer AJM, Cannegieter SC, Caramella M, Meijers JCM, Krediet RT, Simons RM & Rosendaal FR (2008), Fluid loss does not explain coagulation activation during air travel, Thrombosis and Haemostasis 99(6).
- Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR & Hammerstrom J (2007), Incidence and mortality of venous thrombosis: a population-based study, Journal of Thrombosis and Haemostasis 5(4).
- Liem SS, Oemrawsingh PV, Cannegieter SC, Le Cessie S, Schreur J, Rosendaal FR & Schalij MJ (2007), Cardiovascular risk in young apparently healthy descendents from Asian Indian migrants in The Netherlands: The SHIVA study, Circulation 115(21).
- Coppens M, Schreijer AJM, Berger FH, Cannegieter SC, Rosendaal FR & Buller HR (2007), Mechanical prophylaxis for travellers' thrombosis: a comparison of three interventions that promote venous outflow, Journal of Thrombosis and Haemostasis 5(7).
- Vlieg AV, Christiansen SC, Luddington R, Cannegieter SC, Rosendaal FR & Baglin TP (2007), Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence, British Journal of Haematology 138(6).
- Kuipers S, Schreijer AJM, Cannegieter SC, Buller HR, Rosendaal FR & Middeldorp S (2007), Travel and venous thrombosis: a systematic review, Journal of Internal Medicine 262(6).
- Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Buller HR & Rosendaal FR (2007), The absolute risk of venous thrombosis after air travel: A cohort study of 8,755 employees of international organisations, PLoS Medicine 4(9).
- Kuipers S, Cannegieter SC, Middeldorp S, Rosendaal FR & Buller HR (2006), Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences, Journal of Thrombosis and Haemostasis 4(11).
- Schreijer AJM, Cannegieter SC, Meijers JCM, Middeldorp S, Buller HR & Rosendaal FR (2006), Activation of coagulation system during air travel: a crossover study, Lancet 367(9513).
- Schreijer AJM, Cannegieter SC, Giordano PC, Rosendaal FR & Helmerhorst FM (2006), A case of thrombosis: Not sickle cell, Thrombosis and Haemostasis 95(2).
- Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP & Rosendaal FR (2005), Thrombophilia, clinical factors, and recurrent venous thrombotic events, Journal of the American Medical Association 293(19).
- Cannegieter SC & Rosendaal FR (2005), Clinical factors and recurrent venous thrombotic events - Reply, Journal of the American Medical Association 294(12).
- Schreijer AJM, Cannegieter SC & Rosendaal FR (2003), Effect of prolonged sitting on thrombin generation: not evidenced yet: rebuttal, Journal of Thrombosis and Haemostasis 1(12).
- Bestuurslid
- Academic Editor wetenschappelijk tijdschrift
- Lid Wetenschapscommissie
- Lid Wetenschappelijke Adviesraad